Find Studies and Clinical Trials

Understanding the Basics of Studies and Clinical Trials

Deciding whether you should participate in a study or clinical trial is an important personal decision. Your decision is best made with a full understanding of the process of drug development and your specific role. While the choice is ultimately yours, we also highly recommend that you first discuss it with your physician, as well as members of your family and friends. Learn more about our clinical trials and how you can get involved.

The Crohn's & Colitis Foundation maintains a comprehensive database of studies, clinical trials, and other research into Crohn's Disease and Ulcerative Colitis. You can use the search tool below to access listings for current and upcoming opportunities to participate in this research. Search by keyword, or specify which disease you have been diagnosed with, as well as your location, to help narrow your search. 

  • CCFA Partners
  • Clinical Research Alliance
  • Clinical Trials
  • Genetics Initiative
  • Human Gut Microbiome Initiative
  • PRO-KIIDS Pediatric IBD
  • Other
635841311|*|32.876425|*|-117.22745700000002|*|University of California San Diego, 9444 Medical Center Drive, La Jolla, CA 92037, USA|*|San Diego|*|92037|*|CA|*| A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-25-1.html|*||*|,CA625402831|*|37.1470853|*|-80.4138595|*|110 Akers Farm Road Northeast, Christiansburg, VA 24073, USA|*|Christiansburg|*|24073|*|VA|*| A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-20.html|*||*|,VA625400715|*|36.1279695|*|-86.84372739999998|*|4230 Harding Pike #529, Nashville, TN 37205, USA|*|Nashville|*|37205|*|TN|*| A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-19.html|*||*|,TN635839175|*|40.1167446|*|-88.21448570000001|*|611 West Park Street, Urbana, IL 61801, USA|*|Urbana|*|61801|*|IL|*| A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-24.html|*||*|,IL635840882|*|45.5116427|*|-122.77538349999998|*|9701 Southwest Barnes Road #300, Portland, OR 97225, USA|*|Portland|*|97225|*|OR|*| A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-25.html|*||*|,OR625604650|*|39.8551631|*|-84.27240569999998|*|9000 North Main Street #405, Dayton, OH 45415, USA|*|Dayton|*|45415|*|OH|*| A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-15-1.html|*||*|,OH625603526|*|39.8551631|*|-84.27240569999998|*|9000 North Main Street #405, Dayton, OH 45415, USA|*|Dayton|*|45415|*|OH|*| A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-15.html|*||*|,OH625506749|*|38.9967159|*|-76.516616|*|621 Ridgely Avenue #403, Annapolis, MD 21401, USA|*|Annapolis|*|21401|*|MD|*| A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-3.html|*||*|,MD625512028|*|39.739686|*|-105.07482829999998|*|7000 West Colfax Avenue, Lakewood, CO 80214, USA|*|Lakewood|*|80214|*|CO|*| A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-8.html|*||*|,CO625509998|*|42.9907685|*|-87.95015339999998|*|2801 West Kinnickinnic River Parkway, Milwaukee, WI 53215, USA|*|Milwaukee|*|53215|*|WI|*| A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-6.html|*||*|,WI625599118|*|38.9638599|*|-77.0904731|*|5550 Friendship Boulevard #90, Chevy Chase, MD 20815, USA|*|Chevy Chase|*|20815|*|MD|*| A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-10.html|*||*|,MD625606870|*|32.8326031|*|-83.62967200000003|*|610 3rd Street #204, Macon, GA 31201, USA|*|Macon|*|31201|*|GA|*| A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-19.html|*||*|,GA625606268|*|37.1470624|*|-80.41386410000001|*|110 Akers Farm Road Northeast|*|Christiansburg|*|24073|*|Virginia|*| A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-18.html|*||*|,VA776258445|*|42.3360887|*|-71.10670670000002|*|75 Francis Street|*|Boston|*|02115|*|Massachusetts|*| A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN-LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (TUSCANY STUDY B7541002)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7541002/a-phase-2a-multicenter-5.html|*||*|,MA631004477|*|43.0763329|*|-89.43133119999999|*|University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI 53792, USA|*|Madison|*|53792|*|WI|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-38.html|*|H6/517 CSC - MC 5124|*|,WI630265260|*|34.0500849|*|-84.2236226|*|Saddle Brook Shopping Center, 10945 State Bridge Road #401, Alpharetta, GA 30022, USA|*|Alpharetta|*|30022|*|GA|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-14.html|*||*|,GA630271271|*|41.6823016|*|-81.3003625|*|9485 Mentor Avenue #105, Mentor, OH 44060, USA|*|Mentor|*|44060|*|OH|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-16.html|*||*|,OH631003146|*|30.0064271|*|-95.28971990000002|*|8901 F-M 1960 Road West, Humble, TX 77338, USA|*|Humble|*|77338|*|TX|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-36.html|*||*|,TX630683332|*|39.3835036|*|-74.57428329999999|*|3205 Fire Road, Egg Harbor Township, NJ 08234, USA|*|Egg Harbor Township|*|08234|*|NJ|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-26.html|*||*|,NJ631020933|*|33.969958|*|-84.54820899999999|*|711 Canton Road Northeast #300, Marietta, GA 30060, USA|*|Marietta|*|30060|*|GA|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-43.html|*||*|,GA630243643|*|32.502281|*|-92.111987|*|608 Grammont Street, Monroe, LA 71201, USA|*|Monroe|*|71201|*|LA|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-4.html|*||*|,LA630245348|*|42.5892055|*|-83.16952900000001|*|4550 Investment Drive #260, Troy, MI 48098, USA|*|Troy|*|48098|*|MI|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-5.html|*||*|,MI630272075|*|30.411395|*|-97.70615599999996|*|12221 North Mopac Expressway, Austin, TX 78758, USA|*|Austin|*|78758|*|TX|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-17.html|*||*|,TX630252378|*|28.260524|*|-82.706883|*|7114 Congress Street, New Port Richey, FL 34653, USA|*|New Port Richey|*|34653|*|FL|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-8.html|*||*|,FL631028836|*|27.969784|*|-82.7489779|*|2147 Northeast Coachman Road, Clearwater, FL 33765, USA|*|Clearwater|*|33765|*|FL|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-46.html|*||*|,FL630997251|*|30.408083|*|-88.76277199999998|*|3890 Bienville Boulevard, Ocean Springs, MS 39564, USA|*|Ocean Springs|*|39564|*|MS|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-34.html|*||*|,MS630265047|*|42.0885944|*|-70.9884338|*|189 Quincy Street, Brockton, MA 02302, USA|*|Brockton|*|02302|*|MA|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-13.html|*||*|,MA630453136|*|40.1167446|*|-88.21448570000001|*|611 West Park Street, Urbana, IL 61801, USA|*|Urbana|*|61801|*|IL|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-19.html|*||*|,IL630878675|*|40.7453522|*|-73.98014510000002|*|215 Lexington Avenue, New York, NY 10016, USA|*|New York|*|10016|*|NY|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-31.html|*||*|,NY631002348|*|38.8683915|*|-77.23438859999999|*|3002 Williams Drive #301, Fairfax, VA 22031, USA|*|Fairfax|*|22031|*|VA|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-35.html|*||*|,VA630323429|*|41.3767571|*|-72.9048113|*|2200 Whitney Avenue #370, Hamden, CT 06518, USA|*|Hamden|*|06518|*|CT|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-18.html|*||*|,CT630454124|*|45.7877451|*|-108.51313479999999|*|801 North 29th Street, Billings, MT 59101, USA|*|Billings|*|59101|*|MT|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-21.html|*||*|,MT630242744|*|25.968524|*|-80.14851999999996|*|20880 West Dixie Highway #103, Miami, FL 33180, USA|*|Miami|*|33180|*|FL|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-3.html|*||*|,FL630262171|*|38.9967159|*|-76.516616|*|621 Ridgely Avenue #401, Annapolis, MD 21401, USA|*|Annapolis|*|21401|*|MD|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-11.html|*||*|,MD631031161|*|39.054213|*|-95.69233400000002|*|720 Southwest Lane Street, Topeka, KS 66606, USA|*|Topeka|*|66606|*|KS|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-47.html|*||*|,KS631026793|*|40.8831082|*|-74.01069819999998|*|718 Teaneck Road, Teaneck, NJ 07666, USA|*|Teaneck|*|07666|*|NJ|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-45.html|*||*|,NJ630267513|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road #206, Chesterfield, MI 48047, USA|*|Chesterfield|*|48047|*|MI|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-15.html|*||*|,MI630241801|*|28.2295253|*|-81.30879600000003|*|3505 Progress Lane, Saint Cloud, FL 34769, USA|*|Saint Cloud|*|34769|*|FL|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-2.html|*||*|,FL631020469|*|28.5979893|*|-81.35827929999999|*|701 West Morse Boulevard, Winter Park, FL 32789, USA|*|Winter Park|*|32789|*|FL|*| A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-42.html|*||*|,FL640883136|*|43.0164574|*|-81.27163289999999|*|Windermere Road|*|London|*|N6A|*|Ontario|*| A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-10.html|*|Room C8-131|*|640704332|*|29.633344|*|-82.33847600000001|*|2001 Southwest 13th Street|*|Gainesville|*|32608|*|Florida|*| A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-6.html|*||*|,FL640705923|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*| A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-8.html|*|Suite 206 |*|,MI640886774|*|43.2527494|*|-79.85959909999997|*|Main Street East|*|Hamilton|*|L8N|*|Ontario|*| A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-11.html|*|Room 3N8E |*|640888325|*|37.4978455|*|-77.46685400000001|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|Virginia|*| A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-13.html|*|Gastroenterology, 111-N|*|,VA640701910|*|40.7703804|*|-111.83574809999999|*|30 North 1900 East|*|Salt Lake City|*|84132|*|Utah|*| A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-3.html|*|SOM 4R118|*|,UT806461872|*|37.4978455|*|-77.46685400000001|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|Virginia|*| Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-4.html|*||*|,VA512148652|*|37.4363806|*|-122.174982|*|Lucile Packard Children’s Hospital, Stanford University, 725 Welch Road, Palo Alto, CA 94304, USA|*|Palo Alto|*|94304|*|CA|*| Out-of-Pocket Cost Burden in Pediatric Inflammatory Bowel Disease.|*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*|,female,male|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/sponsor-profiles/stanford-1.html|*||*|,CA807297189|*|41.3767488|*|-72.90484049999998|*|2200 Whitney Avenue|*|Hamden|*|06518|*|Connecticut|*| PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therap|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-9.html|*||*|,CT806843862|*|32.4843733|*|-93.77536559999999|*|3217 Mabel Street|*|Shreveport|*|71103|*|Louisiana|*| PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-2.html|*||*|,MI,MA,FL,AL,WI,CA,KS,KY,LA,MD,NC,CT724140053|*|39.38348939999999|*|-74.57429769999999|*|3205 Fire Road|*|Egg Harbor Township|*|08234|*|New Jersey|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-12.html|*||*|,NJ724162190|*|28.5979386|*|-81.35830290000001|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|Florida|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-15.html|*||*|,FL724105862|*|41.461833|*|-81.49282299999999|*|3619 Park East Drive|*|Beachwood|*|44122|*|Ohio|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-3.html|*|Suite 300|*|,OH724111613|*|45.0249518|*|-93.47970670000001|*|15700 37th Avenue North|*|Minneapolis|*|55446|*|Minnesota|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-5.html|*||*|,MN724099498|*|33.8650241|*|-117.54701210000002|*|1191 Magnolia Avenue|*|Corona|*|92879|*|California|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-1.html|*||*|,CA724108876|*|40.7453522|*|-73.98014510000002|*|215 Lexington Avenue|*|New York|*|10016|*|New York|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-4.html|*|21st Floor|*|,NY724137028|*|39.1330978|*|-84.50013489999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-11.html|*||*|,OH724174792|*|36.8529337|*|-76.19371869999998|*|885 Kempsville Road|*|Norfolk|*|23502|*|Virginia|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-18.html|*||*|,VA724170458|*|25.8673299|*|-80.3125938|*|1490 West 49th Place|*|Hialeah|*|33012|*|Florida|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-17.html|*||*|,FL724129135|*|39.1790459|*|-76.84548010000003|*|7120 Minstrel Way|*|Columbia|*|21045|*|Maryland|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-8.html|*||*|,MD724132431|*|32.9330939|*|-97.108067|*|545 South Nolen Drive|*|Southlake|*|76092|*|Texas|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-9.html|*||*|,TX724102292|*|41.7186995|*|-73.92955310000002|*|243 North Road|*|Poughkeepsie|*|12601|*|New York|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-2.html|*||*|,NY724126433|*|32.8814196|*|-96.76068800000002|*|8230 Walnut Hill Lane|*|Dallas|*|75231|*|Texas|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-7.html|*|Suite 610|*|,TX724134569|*|32.898559|*|-96.95731519999998|*|701 Tuscan Drive|*|Irving|*|75039|*|Texas|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-10.html|*|Suite 110|*|,TX724156914|*|26.1843212|*|-80.2016013|*|4700 North State Road 7|*|Lauderdale Lakes|*|33319|*|Florida|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-13.html|*|Building A|*|,FL724159891|*|32.8326258|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-14.html|*||*|,GA723177353|*||*||*||*||*||*||*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23.html|*||*|,OH,VA,FL,GA,MN,CA,NJ,NY,TX,CO,MD,TN724176974|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-19.html|*||*|,TN724165267|*|36.7417665|*|-76.24615600000004|*|112 Gainsborough Square|*|Chesapeake|*|23320|*|Virginia|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-16.html|*|Suite 200|*|,VA724119344|*|39.5642895|*|-104.88604950000001|*|10103 Parkway Drive|*|Lone Tree|*|80124|*|Colorado|*|A Combined Phase 2/3 Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluation the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead/1100-gs-5745-uc/a-combined-phase-23-6.html|*|Suite 312|*|,CO623940425|*|42.9907685|*|-87.95015339999998|*|2801 West Kinnickinnic River Parkway #1030, Milwaukee, WI 53215, USA|*|Milwaukee|*|53215|*|WI|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-6.html|*||*|,WI625384793|*|26.1593354|*|-81.79095589999997|*|1064 Goodlette Road North, Naples, FL 34102, USA|*|Naples|*|34102|*|FL|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-17.html|*||*|,FL625377912|*|39.8551631|*|-84.27240569999998|*|9000 North Main Street #405, Dayton, OH 45415, USA|*|Dayton|*|45415|*|OH|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-16.html|*||*|,OH623733851|*|38.9967159|*|-76.516616|*|621 Ridgely Avenue #403, Annapolis, MD 21401, USA|*|Annapolis|*|21401|*|MD|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-3.html|*||*|,MD623934113|*|40.7848073|*|-73.7086352|*|1000 Northern Boulevard #160, Great Neck, NY 11020, USA|*|Great Neck|*|11020|*|NY|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-5.html|*||*|,NY624138211|*|35.04796760000001|*|-85.28957600000001|*|979 East 3rd Street, Chattanooga, TN 37403, USA|*|Chattanooga|*|37403|*|TN|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-14.html|*||*|,TN625405664|*|28.5979893|*|-81.35827929999999|*|701 West Morse Boulevard, Winter Park, FL 32789, USA|*|Winter Park|*|32789|*|FL|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-22.html|*||*|,FL625393913|*|36.1279695|*|-86.84372739999998|*|4230 Harding Pike #529, Nashville, TN 37205, USA|*|Nashville|*|37205|*|TN|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-18.html|*||*|,TN623949406|*|39.739686|*|-105.07482829999998|*|7000 West Colfax Avenue, Lakewood, CO 80214, USA|*|Lakewood|*|80214|*|CO|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-8.html|*||*|,CO623972864|*|34.0622718|*|-118.3552952|*|5800 Wilshire Boulevard, Los Angeles, CA 90036, USA|*|Los Angeles|*|90036|*|CA|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-11.html|*||*|,CA623955287|*|35.208552|*|-80.82192199999997|*|2015 Randolph Road #208, Charlotte, NC 28207, USA|*|Charlotte|*|28207|*|NC|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-9.html|*||*|,NC624134149|*|31.223076|*|-85.43550299999998|*|480 Honeysuckle Road, Dothan, AL 36305, USA|*|Dothan|*|36305|*|AL|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-13.html|*||*|,AL623964892|*|38.9638599|*|-77.0904731|*|5550 Friendship Boulevard #90, Chevy Chase, MD 20815, USA|*|Chevy Chase|*|20815|*|MD|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-10.html|*||*|,MD623706094|*||*||*||*||*||*||*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized.html|*||*|,VA,AL,UT,MO,TX,MD,OH,FL,OK,GA,PA,WI,CA,NY,NC,CO,CT623725747|*|35.8235709|*|-78.7058017|*|3100 Duraleigh Road #304, Raleigh, NC 27612, USA|*|Raleigh|*|27612|*|NC|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-2.html|*||*|,NC623946873|*|41.3767571|*|-72.9048113|*|2200 Whitney Avenue #370, Hamden, CT 06518, USA|*|Hamden|*|06518|*|CT|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-7.html|*||*|,CT623974262|*|36.1138625|*|-95.93979990000003|*|3345 South Harvard Avenue #301, Tulsa, OK 74135, USA|*|Tulsa|*|74135|*|OK|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-12.html|*||*|,OK623718992|*|30.3106938|*|-97.74049339999999|*|4201 Marathon Boulevard #202, Austin, TX 78756, USA|*|Austin|*|78756|*|TX|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-1.html|*||*|,TX625403684|*|32.8326031|*|-83.62967200000003|*|610 3rd Street #204, Macon, GA 31201, USA|*|Macon|*|31201|*|GA|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-21.html|*||*|,GA625406626|*|40.4419009|*|-79.9604392|*|Upmc Digestive Disorders Center: Swoger Jason MD, University of Pittsburgh, 200 Lothrop Street, Pittsburgh, PA 15213, USA|*|Pittsburgh|*|15213|*|PA|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-23.html|*||*|,PA625370438|*|41.1542481|*|-111.94184439999998|*|5896 South Ridgeline Drive, South Ogden, UT 84405, USA|*|South Ogden|*|84405|*|UT|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-15.html|*||*|,UT635844360|*|33.9096612|*|-84.35044160000001|*|5671 Peachtree Dunwoody Road Northeast #512, Atlanta, GA 30342, USA|*|Atlanta|*|30342|*|GA|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-26.html|*||*|,GA623734709|*|39.0063676|*|-94.5795248|*|6675 Holmes Road #430, Kansas City, MO 64131, USA|*|Kansas City|*|64131|*|MO|*|A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-double-blind-randomized-4.html|*||*|,MO455366178|*|33.7798217|*|-117.864966|*|1140 West La Veta Avenue #555|*|Orange|*|92868|*|CA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1109-ca.html|*||*|,CA455366182|*|39.878357|*|-104.978308|*|10001 Washington Street|*|Thornton|*|80229|*|CO|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1111-co.html|*||*|,CO455365976|*|42.2825887|*|-83.7267076|*|1500 East Medical Center Drive|*|Ann Arbor|*|48109|*|MI|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1074-mi.html|*||*|,MI455366150|*|38.0315934|*|-84.5092759|*|800 Rose Street|*|Lexington|*|40508|*|KY|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1086-ky.html|*||*|,KY455366138|*|38.6354273|*|-90.2630413|*|660 South Euclid Avenue #8124|*|St. Louis|*|63110|*|MO|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1116-mo.html|*||*|,MO455366158|*|47.6492873|*|-122.3068507|*|1959 Northeast Pacific Street|*|Seattle|*|98195|*|WA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1233-wa.html|*||*|,WA455366146|*|32.935516|*|-97.108444|*|505 South Nolen Drive|*|Southlake|*|76092|*|TX|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1224-tx.html|*||*|,TX455366166|*|33.586|*|-111.794118|*|13400 East Shea Boulevard|*|Scottsdale|*|85259|*|AZ|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1078-az.html|*||*|,AZ455365921|*|37.5394|*|-77.430144|*|1200 East Broad Street|*|Richmond|*|23298|*|VA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1077-va.html|*||*|,VA455366005|*|34.7456729|*|-92.385544|*|10001 Baptist Health Drive|*|Little Rock|*|72205|*|AR|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1112-ar.html|*||*|,AR455365402|*|33.791025|*|-84.283719|*|2665 North Decatur Road #550|*|Decatur|*|30030|*|GA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1068-ga.html|*||*|,GA455366154|*|45.5116691|*|-122.7753981|*|9701 Southwest Barnes Road|*|Portland|*|97225|*|OR|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1076-or.html|*||*|,OR455366192|*|32.880925|*|-111.710639|*|1780 East Florence Boulevard #104|*|Casa Grande|*|85122|*|AZ|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1128-az.html|*||*|,AZ455366186|*|25.844323|*|-80.270576|*|590 East 25th Street #503|*|Hialeah|*|33013|*|FL|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1096-fl.html|*||*|,FL455366174|*|42.0883248|*|-70.9883641|*|189 Quincy Street|*|Brockton|*|02302|*|MA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1198-ma.html|*||*|,MA455365926|*|36.1427786|*|-86.8000741|*|1211 21st Avenue South|*|Nashville|*|37212|*|TN|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1203-tn.html|*||*|,TN455365873|*|28.598041|*|-81.358368|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|FL|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1227-fl.html|*||*|,FL455366134|*|42.2771988|*|-71.7592184|*|55 North Lake Avenue|*|Worcester|*|01605|*|MA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1104-ma.html|*||*|,MA455366017|*|36.1585974|*|-115.1642656|*|1707 West Charleston Boulevard #220|*|Las Vegas|*|89102|*|NV|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1246-nv.html|*||*|,NV455366162|*|25.9722139|*|-80.2990635|*|11460 Interchange Circle North|*|Miramar|*|33025|*|FL|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1097-fl.html|*||*|,FL455365916|*|43.6728634|*|-72.2723196|*|Medical Center Drive|*|Lebanon|*|03766|*|NH|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1090-nh.html|*||*|,NH455366234|*|40.7851016|*|-73.7086053|*|1000 Northern Boulevard #160|*|Great Neck|*|11021|*|NY|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1114-ny.html|*||*|,NY455366021|*|42.6526788|*|-73.7778833|*|47 New Scotland Avenue|*|Albany|*|12208|*|NY|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1232-ny.html|*||*|,NY455366170|*|32.8766678|*|-117.2273397|*|9444 Medical Center Drive|*|San Diego|*|92037|*|CA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1248-ca.html|*||*|,CA455365934|*|28.500235|*|-81.375642|*|3885 Oakwater Circle|*|Orlando|*|32806|*|FL|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1117-fl.html|*||*|,FL455365398|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|TN|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1047-tn.html|*||*|,TN455366130|*|29.709906|*|-95.40283|*|6620 Main Street #1225|*|Houston|*|77030|*|TX|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1089-tx.html|*||*|,TX455365997|*|42.0654997|*|-87.6842835|*|2650 Ridge Avenue|*|Evanston|*|60201|*|IL|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1094-il.html|*||*|,IL455366009|*|25.7874258|*|-80.2130197|*|1120 Northwest 14th Street|*|Miami|*|33136|*|FL|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1214-fl.html|*||*|,FL455366238|*|34.0712014|*|-84.1724617|*|4395 Johns Creek Parkway #130|*|Suwanee|*|30024|*|GA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1069-ga.html|*||*|,GA455365930|*|29.585773|*|-95.630281|*|4760 Sweetwater Boulevard #101|*|Sugar Land|*|77479|*|TX|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1080-tx.html|*||*|,TX455366013|*|39.9864544|*|-105.1026747|*|1000 West South Boulder Road #200|*|Lafayette|*|80026|*|CO|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1108-co.html|*||*|,CO455365869|*|45.0243351|*|-93.4788847|*|15700 37th Avenue North #300|*|Plymouth|*|55446|*|MN|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1081-mn.html|*||*|,MN455366001|*|41.6021951|*|-93.7890357|*|1378 Northwest 124th Street|*|Clive|*|50325|*|IA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1107-ia.html|*||*|,IA455366126|*|41.718495|*|-73.929638|*|243 North Road #304|*|Poughkeepsie|*|12601|*|NY|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1105-ny.html|*||*|,NY454075902|*|41.376484|*|-72.9053689|*|2200 Whitney Avenue #370|*|Hamden|*|06518|*|CT|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1044-ct.html|*||*|,CT455366142|*|37.49646|*|-77.465839|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|VA|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1099-va.html|*||*|,VA455365984|*|39.386024|*|-76.606981|*|7402 York Road #100|*|Towson|*|21204|*|MD|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1082-md.html|*||*|,MD455365865|*|35.901785|*|-79.0535174|*|130 Mason Farm Road|*|Chapel Hill|*|27599|*|NC|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1103-nc.html|*||*|,NC455365993|*|39.158509|*|-91.876767|*|714 Medical Park Drive|*|Mexico|*|65265|*|MO|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1118-mo.html|*||*|,MO455365988|*|43.066011|*|-88.04867|*|2645 North Mayfair Road #200|*|Milwaukee|*|53226|*|WI|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1101-wi.html|*||*|,WI455365375|*|28.831933|*|-82.334981|*|411 West Highland Boulevard|*|Inverness|*|34452|*|FL|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1045-fl.html|*||*|,FL455366122|*|42.860259|*|-85.716263|*|2093 Health Drive Southwest|*|Wyoming|*|49519|*|MI|*|A double-blind, randomized, placebo controlled, parallel, dose-ranging study to evaluate the efficacy and safety of PF-00547659 in subjects with moderate to severe ulcerative colitis (TURANDOT)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/turandot/1067-mi.html|*||*|,MI682187167|*|33.2958243|*|-111.87664219999999|*|600 South Dobson Road|*|Chandler|*|85224|*|Arizona|*|A long term Non-International Registry to Asses Safety and Effectiveness of Humira in Patients with Moderately to Severe Active Ulcerative Colitis |*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/abbvie/a-long-term-non-international-1.html|*||*|,AZ817038811|*|32.4438631|*|-93.71252170000002|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-9.html|*||*|,LA817044676|*|39.6221207|*|-77.6838717|*|11110 Medical Campus Road|*|Hagerstown|*|21742|*|Maryland|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-14.html|*||*|,MD817045501|*|35.0536652|*|-85.18214990000001|*|6035 Shallowford Road|*|Chattanooga|*|37421|*|Tennessee|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-16.html|*||*|,TN817035380|*|36.1462952|*|-95.96682340000001|*|1145 South Utica Avenue|*|Tulsa|*|74104|*|Oklahoma|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-3.html|*||*|,OK817037073|*|25.8208329|*|-80.28562779999999|*|286 Westward Drive|*|Miami Springs|*|33166|*|Florida|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-6.html|*||*|,FL817036351|*|31.2231436|*|-85.43547719999998|*|480 Honeysuckle Road|*|Dothan|*|36305|*|Alabama|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-5.html|*||*|,AL817039587|*|28.2545894|*|-82.18665809999999|*|38135 Market Square|*|Zephyrhills|*|33542|*|Florida|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-10.html|*||*|,FL817034697|*|39.0069453|*|-94.57777329999999|*|6675 Holmes Road|*|Kansas City|*|64131|*|Missouri|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-2.html|*||*|,MO817040628|*|32.9354834|*|-97.1084679|*|505 South Nolen Drive|*|Southlake|*|76092|*|Texas|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-12.html|*||*|,TX817040189|*|29.5181439|*|-98.56775240000002|*|8550 Datapoint Drive|*|San Antonio|*|78229|*|Texas|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-11.html|*||*|,TX817045102|*|29.6332323|*|-82.33886940000002|*|2001 Southwest 13th Street|*|Gainesville|*|32608|*|Florida|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-15.html|*||*|,FL817041279|*|38.0360467|*|-78.45516700000002|*|325 Winding River Lane|*|Charlottesville|*|22911|*|Virginia|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-13.html|*||*|,VA817038475|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-8.html|*||*|,OH817046613|*|41.3735616|*|-81.83208049999996|*|18660 Bagley Road|*|Middleburg Heights|*|44130|*|Ohio|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-19.html|*||*|,OH817046228|*|35.8210717|*|-78.70391269999999|*|3100 Blue Ridge Road|*|Raleigh|*|27612|*|North Carolina|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-18.html|*||*|,NC817035879|*|32.502281|*|-92.111987|*|608 Grammont Street|*|Monroe|*|71201|*|Louisiana|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-4.html|*||*|,LA817037754|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3896/a-long-term-extension-study-7.html|*||*|,FL815405557|*|32.502281|*|-92.111987|*|608 Grammont Street|*|Monroe|*|71201|*|Louisiana|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-4.html|*||*|,LA815412790|*|35.8210717|*|-78.70391269999999|*|3100 Blue Ridge Road|*|Raleigh|*|27612|*|North Carolina|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-18.html|*||*|,NC815240718|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-3.html|*||*|,TN815410821|*|44.0571485|*|-103.23131380000001|*|2820 Mount Rushmore Road|*|Rapid City|*|57701|*|South Dakota|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-15.html|*||*|,SD815407891|*|28.2545894|*|-82.18665809999999|*|38135 Market Square|*|Zephyrhills|*|33542|*|Florida|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-10.html|*||*|,FL815409373|*|32.9354834|*|-97.1084679|*|505 South Nolen Drive|*|Southlake|*|76092|*|Texas|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-12.html|*||*|,TX815407631|*|32.4438631|*|-93.71252170000002|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-9.html|*||*|,LA815406083|*|31.2231436|*|-85.43547719999998|*|480 Honeysuckle Road|*|Dothan|*|36305|*|Alabama|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-5.html|*||*|,AL815406486|*|25.8208329|*|-80.28562779999999|*|286 Westward Drive|*|Miami Springs|*|33166|*|Florida|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-6.html|*||*|,FL815409911|*|38.0360467|*|-78.45516700000002|*|325 Winding River Lane|*|Charlottesville|*|22911|*|Virginia|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-13.html|*||*|,MI,VA,AL,AZ,MO,LA,TX,MD,TN,SD,OH,FL,WI,NC,CO815404594|*|39.0069453|*|-94.57777329999999|*|6675 Holmes Road|*|Kansas City|*|64131|*|Missouri|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-2.html|*||*|,MO815411647|*|39.9717119|*|-105.09442509999997|*|380 Empire Road|*|Lafayette|*|80026|*|Colorado|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-16.html|*||*|,CO815407195|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-8.html|*||*|,OH815412227|*|35.0536652|*|-85.18214990000001|*|6035 Shallowford Road|*|Chattanooga|*|37421|*|Tennessee|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-17.html|*||*|,TN815408313|*|29.5181439|*|-98.56775240000002|*|8550 Datapoint Drive|*|San Antonio|*|78229|*|Texas|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-11.html|*||*|,TX815406905|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-7.html|*||*|,FL815410337|*|39.6221207|*|-77.6838717|*|11110 Medical Campus Road|*|Hagerstown|*|21742|*|Maryland|*|A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-418-3899/a-long-term-extension-study-14.html|*||*|,MD340014101|*|29.7099106|*|-95.4014139|*|1709 Dryden Rd|*|Houston|*|77030|*|TX|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-TX.html|*||*|,TX340013903|*|40.7700703|*|-73.9580246|*||*||*|10021|*|NY|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NY-1.html|*||*|,NY417470341|*||*||*||*||*||*||*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study.html|*||*|,CA,FL,IL,IA,KY,MA,MN,MO,NH,NY,NC,OH,PA,RI,TN,TX,VT,VA,WI340014081|*|36.1390165|*|-86.7969244|*||*|Nashville|*|37212|*|TN|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-TN.html|*||*|,TN340013735|*|40.1146839|*|-88.207964|*|221 N Broadway Ave|*|Urbana|*|61801|*|IL|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-IL-2.html|*||*|,IL340013830|*|44.0221363|*|-92.4666658|*|200 1st St SW|*|Rochester|*|55902|*|MN|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MN-2.html|*||*|,MN340014159|*|43.043614|*|-88.020787|*|8701 W Watertown Plank Rd|*|Milwaukee|*|53226|*|WI|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-WI-2.html|*||*|,WI340013875|*|35.930263|*|-79.0545828|*|880 Martin Luther King Jr Blvd|*|Chapel Hill|*|27514|*|NC|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NC-2.html|*||*|,NC340013660|*|34.073582|*|-118.380947|*|8635 W 3rd St|*|Los Angeles|*|90048|*|CA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-CA-1.html|*||*|,CA340013686|*|29.63923|*|-82.34331|*||*|Gainesville|*|32610|*|FL|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-FL.html|*||*|,FL340013674|*|37.784511|*|-122.440412|*|2330 Post St|*|San Francisco|*|94115|*|CA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-CA-2.html|*||*|,CA340014066|*|41.8139504|*|-71.4124533|*|90 Plain St|*|Providence|*|02903|*|RI|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-RI.html|*||*|,RI340013801|*|42.336226|*|-71.072918|*|85 E Concord St|*|Boston|*|02118|*|MA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MA-3.html|*||*|,MA340014129|*|44.4795901|*|-73.2005961|*|1 S Prospect St|*|Burlington|*|05401|*|VT|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-VT.html|*||*|,VT340013751|*|38.0328237|*|-84.5067424|*||*|Lexington|*|40536|*|KY|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-KY.html|*||*|,KY340013767|*|42.339904|*|-71.0898892|*||*|Boston|*|02115|*|MA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MA-1.html|*|75 Francis Street|*|,MA340013786|*|42.3618645|*|-71.0654433|*|165 Cambridge St|*|Boston|*|02114|*|MA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MA-2.html|*||*|,MA340014142|*|43.0772547|*|-89.430773|*||*|Madison|*|53792|*|WI|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-WI-1.html|*||*|,WI340013861|*|36.0906339|*|-80.2715805|*|Medical Center Blvd|*|Winston-Salem|*|27103|*|NC|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NC-1.html|*||*|,NC340013816|*|45.0244667|*|-93.4796711|*|15700 37th Ave N|*|Plymouth|*|55446|*|MN|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MN-1.html|*||*|,MN340013888|*|43.64|*|-72.25|*||*|Lebanon|*|03756|*|NH|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NH.html|*||*|,NH340013847|*|38.6212468|*|-90.2526163|*||*|St Louis|*|63110|*|MO|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MO.html|*||*|,MO340013720|*|41.7900327|*|-87.5964047|*|5751 S Woodlawn Ave|*|Chicago|*|60637|*|IL|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-IL-1.html|*||*|,IL625603073|*|41.1542481|*|-111.94184439999998|*|5896 South Ridgeline Drive, South Ogden, UT 84405, USA|*|South Ogden|*|84405|*|UT|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-14.html|*||*|,UT634895750|*|40.1167446|*|-88.21448570000001|*|611 West Park Street, Urbana, IL 61801, USA|*|Urbana|*|61801|*|IL|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-21.html|*||*|,IL625601430|*|31.223076|*|-85.43550299999998|*|480 Honeysuckle Road, Dothan, AL 36305, USA|*|Dothan|*|36305|*|AL|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-12.html|*||*|,AL625503550|*|35.8235709|*|-78.7058017|*|3100 Duraleigh Road #304, Raleigh, NC 27612, USA|*|Raleigh|*|27612|*|NC|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-2.html|*||*|,NC625604949|*|26.1431418|*|-81.78861699999999|*|1064 Goodlette Road, Naples, FL 34102, USA|*|Naples|*|34102|*|FL|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-16.html|*||*|,FL634908689|*|45.5116427|*|-122.77538349999998|*|9701 Southwest Barnes Road #300, Portland, OR 97225, USA|*|Portland|*|97225|*|OR|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-22.html|*||*|,OR625509043|*|40.7848073|*|-73.7086352|*|1000 Northern Boulevard, Great Neck, NY 11020, USA|*|Great Neck|*|11020|*|NY|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-5.html|*||*|,NY625510855|*|41.3767571|*|-72.9048113|*|2200 Whitney Avenue #370, Hamden, CT 06518, USA|*|Hamden|*|06518|*|CT|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-7.html|*||*|,CT625513210|*|35.208552|*|-80.82192199999997|*|2015 Randolph Road #208, Charlotte, NC 28207, USA|*|Charlotte|*|28207|*|NC|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-9.html|*||*|,NC625601845|*|35.04796760000001|*|-85.28957600000001|*|979 East 3rd Street, Chattanooga, TN 37403, USA|*|Chattanooga|*|37403|*|TN|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-13.html|*||*|,TN625508190|*|39.0063676|*|-94.5795248|*|6675 Holmes Road #430, Kansas City, MO 64131, USA|*|Kansas City|*|64131|*|MO|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-4.html|*||*|,MO625437260|*|34.0622718|*|-118.3552952|*|5800 Wilshire Boulevard, Los Angeles, CA 90036, USA|*|Los Angeles|*|90036|*|CA|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/CD-11-1.html|*||*|,CA625432711|*|40.4419009|*|-79.9604392|*|Upmc Digestive Disorders Center: Swoger Jason MD, University of Pittsburgh, 200 Lothrop Street, Pittsburgh, PA 15213, USA|*|Pittsburgh|*|15213|*|PA|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/CD-23.html|*||*|,PA625600509|*|36.1138625|*|-95.93979990000003|*|3345 South Harvard Avenue #301, Tulsa, OK 74135, USA|*|Tulsa|*|74135|*|OK|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-11.html|*||*|,OK625498070|*|30.3106938|*|-97.74049339999999|*|4201 Marathon Boulevard #202, Austin, TX 78756, USA|*|Austin|*|78756|*|TX|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-1.html|*||*|,TX634928418|*|33.9096612|*|-84.35044160000001|*|5671 Peachtree Dunwoody Road Northeast #512, Atlanta, GA 30342, USA|*|Atlanta|*|30342|*|GA|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-24.html|*||*|,GA625605739|*|36.1279695|*|-86.84372739999998|*|4230 Harding Pike #529, Nashville, TN 37205, USA|*|Nashville|*|37205|*|TN|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-17.html|*||*|,TN625607548|*|28.5979893|*|-81.35827929999999|*|701 West Morse Boulevard, Winter Park, FL 32789, USA|*|Winter Park|*|32789|*|FL|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-20.html|*||*|,FL707708144|*||*||*||*||*||*||*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-25.html|*||*|,TX634910301|*|32.876425|*|-117.22745700000002|*|University of California San Diego, 9444 Medical Center Drive, La Jolla, CA 92037, USA|*|San Diego|*|92037|*|CA|*|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/serene/a-multicenter-randomized-23.html|*||*|,CA668140322|*|28.6373981|*|-81.36448250000001|*|260 Lookout Place|*|Maitland|*|32751|*|Florida|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-20.html|*|Suite 201|*|,FL668132351|*|28.500026|*|-81.37553869999999|*|3885 Oakwater Circle|*|Orlando|*|32806|*|Florida|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-1.html|*||*|,FL668135205|*|38.9967159|*|-76.516616|*|621 Ridgely Avenue|*|Annapolis|*|21401|*|Maryland|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-6.html|*|Suite 403|*|,MD668144713|*|53.5216094|*|-113.52209170000003|*|8540 112 Street Northwest|*|Edmonton|*|T6G 2L7|*|Alberta|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-33.html|*||*|,AB668138438|*|40.1178595|*|-88.21384189999998|*|611 West Park Street|*|Urbana|*|61801|*|Illinois|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-11.html|*|T1 DHC|*|,IL668140506|*|26.1594033|*|-81.7911042|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-21.html|*||*|,FL668144457|*|49.9025587|*|-97.15713840000001|*|820 Sherbrook Street|*|Winnipeg|*|R3A 1R9|*|Manitoba|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-32.html|*||*|668137554|*|42.9899706|*|-87.95078639999997|*|2801 West Kinnickinnic River Parkway|*|Milwaukee|*|53215|*|Wisconsin|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-8.html|*|Suite 1030|*|,WI668141115|*|40.216683|*|-75.5418765|*|420 West Linfield-Trappe Road|*|Limerick|*|19468|*|Pennsylvania|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-24.html|*|Building B, Suite 101|*|,PA668143711|*|39.054213|*|-95.69233400000002|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-29.html|*||*|,KS668144138|*|18.466224|*|-66.10572439999999|*||*|San Juan|*|00936|*|San Juan|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-31.html|*||*|668138599|*|35.2085489|*|-80.8219254|*|2015 Randolph Road|*|Charlotte|*|28207|*|North Carolina|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-12.html|*|Suite 208|*|,NC668132037|*||*||*||*||*||*||*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1.html|*||*|,VA,AL,MN,UT,KS,KY,AB,TX,TN,MD,OK,FL,GA,PA,IL,WI,CA,NY,NC,CO668138924|*|38.9638599|*|-77.0904731|*|5550 Friendship Boulevard|*|Chevy Chase|*|20815|*|Maryland|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-13.html|*|Suite T-90|*|,MD668143391|*|36.1462944|*|-95.96679|*|1145 South Utica Avenue|*|Tulsa|*|74104|*|Oklahoma|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-27.html|*|Suite 807|*|,OK668143542|*|40.7703804|*|-111.83574809999999|*|30 North 1900 East|*|Salt Lake City|*|84132|*|Utah|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-28.html|*|SOM4R118|*|,UT668133584|*|38.0311811|*|-78.49887230000002|*|1215 Lee Street|*|Charlottesville|*|22903|*|Virginia|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-2.html|*||*|,VA668135009|*|33.7793632|*|-117.86510399999997|*|1140 West La Veta Avenue|*|Orange|*|92868|*|California|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-5.html|*|Suite 555|*|,CA668139137|*|28.831933|*|-82.33498100000003|*|411 West Highland Boulevard|*|Inverness|*|34452|*|Florida|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-14.html|*||*|,FL668140871|*|32.9330939|*|-97.108067|*|545 South Nolen Drive|*|Southlake|*|76092|*|Texas|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-23.html|*||*|,TX668139913|*|45.0249518|*|-93.47970670000001|*|15700 37th Avenue North|*|Minneapolis|*|55446|*|Minnesota|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-18.html|*|Suite 300|*|,MN668133803|*|36.0895869|*|-80.26857869999998|*|1 Medical Center Boulevard|*|Winston-Salem|*|27103|*|North Carolina|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-3.html|*||*|,NC668137835|*|40.7848073|*|-73.7086352|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-9.html|*|Suite 160|*|,NY668143868|*|35.1100966|*|-89.7963944|*|1310 Wolf Park Road|*|Germantown|*|38138|*|Tennessee|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-30.html|*||*|,TN668142411|*|37.265959|*|-79.93974029999998|*|101 Elm Avenue|*|Roanoke|*|24013|*|Virginia|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-26.html|*|2nd Floor R&D|*|,VA668134158|*|38.2481197|*|-85.74672140000001|*|401 East Chestnut Street|*|Louisville|*|40202|*|Kentucky|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-4.html|*|Suite 460|*|,KY668138201|*|39.7685402|*|-105.08418599999999|*|7760 West 38th Avenue|*|Wheat Ridge|*|80033|*|Colorado|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-10.html|*|Suite 100|*|,CO668140179|*|33.4799052|*|-86.78783609999999|*|1 Independence Plaza|*|Homewood|*|35209|*|Alabama|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-19.html|*|Suite 900|*|,AL668139587|*|26.0204249|*|-80.17921130000002|*|1150 North 35th Avenue|*|Hollywood|*|33021|*|Florida|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-16.html|*|Suite 445|*|,FL668141323|*|28.5979386|*|-81.35830290000001|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|Florida|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-25.html|*|Suite A|*|,FL668139721|*|32.876425|*|-117.22745700000002|*|9444 Medical Center Drive|*|San Diego|*|92037|*|California|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-17.html|*|ECOB 2-048|*|,CA668135410|*|29.6507708|*|-95.17000989999997|*|4001 Preston Road|*|Pasadena|*|77505|*|Texas|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-7.html|*||*|,TX668140688|*|33.971208|*|-83.41052300000001|*|2350 Prince Avenue|*|Athens|*|30606|*|Georgia|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-22.html|*|Suite 8|*|,GA668139364|*|43.0660867|*|-88.0485061|*|2645 North Mayfair Road|*|Wauwatosa|*|53226|*|Wisconsin|*|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of INVESTIGATIONAL PRODUCT for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/m13-740-celest-study/a-multicenter-randomized-1-15.html|*|Suite 200|*|,WI442976271|*|39.264825|*|-76.6991804|*|4660 Wilkens Avenue #303|*|Baltimore|*|21229|*|MD|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-md.html|*||*|,MD440902158|*|40.7851075|*|-73.7085555|*|1000 Northern Boulevard #160|*|Great Neck|*|11020|*|NY|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-ny.html|*||*|,NY442976248|*|41.376484|*|-72.9053689|*|2200 Whitney Avenue|*|Hamden|*|06518|*|CT|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-ct.html|*||*|,CT440890477|*|28.500235|*|-81.375642|*|3885 Oakwater Circle|*|Orlando|*|32806|*|FL|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-fl-1.html|*||*|,FL440899634|*|39.383257|*|-74.57416|*|3205 Fire Road|*|Egg Harbor Township|*|08234|*|NJ|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-nj-1.html|*||*|,NJ442976296|*|32.7406053|*|-117.162408|*|3330 3rd Avenue #303|*|San Diego|*|92101|*|CA|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-ca-2.html|*||*|,CA440899640|*|42.5882173|*|-83.1693786|*|4550 Investment Drive #260|*|Troy|*|48098|*|MI|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-mi.html|*||*|,MI440902128|*|41.6825663|*|-81.2993753|*|9485 Mentor Avenue #105|*|Mentor|*|44060|*|OH|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-oh.html|*||*|,OH440890572|*|29.6491178|*|-95.1379946|*||*|Pasadena|*|77505|*|TX|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-tx.html|*|4001 Preston Avenue, Suite 125|*|,TX440902149|*|42.9911995|*|-87.9495579|*|2801 West Kinnickinnic River Parkway #1030|*|Milwaukee|*|53215|*|WI|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-wi.html|*||*|,WI440900680|*|39.447952|*|-75.040087|*|602 West Sherman Avenue|*|Vineland|*|08360|*|NJ|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-nj-2.html|*||*|,NJ440902140|*|40.0670797|*|-76.3534888|*|2104 Harrisburg Pike #300|*|Lancaster|*|17601|*|PA|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-pa.html|*||*|,PA442976256|*|32.7251389|*|-117.1620586|*|300 Fir Street #1603|*|San Diego|*|92101|*|CA|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-ca-1.html|*||*|,CA436430574|*||*||*||*||*||*||*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/octave-study.html|*||*|,AL,CA,CT,FL,KS,MD,MI,NJ,NY,NC,OH,PA,TX,WI442976288|*|39.8828|*|-74.9247|*|406 Lippincott Drive|*|Evesham Township|*|08053|*|NJ|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-nj-3.html|*||*|,NJ442976280|*|26.1593285|*|-81.7911031|*|1064 Goodlette Road North|*|Naples|*||*|FL|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-fl-2.html|*||*|,FL442976262|*|36.0826939|*|-79.82423|*|520 North Elam Avenue|*|Greensboro|*|27403|*|NC|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-nc.html|*||*|,NC440899646|*|39.054213|*|-95.692334|*|720 Southwest Lane Street|*|Topeka|*|66606|*|KS|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-ks.html|*||*|,KS440890576|*|30.682226|*|-88.127932|*|108 Interstate 65 Service Road South|*|Creola|*|36525|*|AL|*|A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/study-al.html|*||*|,AL756457514|*|35.9017871|*|-79.05351969999998|*|130 Mason Farm Road|*|Chapel Hill|*|27514|*|North Carolina|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-14.html|*|CB #7080|*|,NC756460558|*|40.7424757|*|-73.9788332|*|232 East 30th Street|*|New York|*|10016|*|New York|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-18.html|*||*|,NY756464785|*|34.13673000000001|*|-117.37160080000001|*|2006 North Riverside Avenue|*|Rialto|*|92377|*|California|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-21.html|*|Suite A|*|,CA758346465|*|41.8945828|*|-87.62317059999998|*|676 North Saint Clair Street|*|Chicago|*|60611|*|Illinois|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-13-1.html|*|Suite 1400|*|,IL782941407|*|26.159403|*|-81.7911229|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-24.html|*||*|,FL756054992|*|30.2507979|*|-81.5858493|*|4800 Belfort Road|*|Jacksonville|*|32256|*|Florida|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-10.html|*|Suite 301|*|,FL756051137|*|38.9638736|*|-77.09046269999999|*|5550 Friendship Boulevard|*|Chevy Chase|*|20815|*|Maryland|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-4.html|*|Suite T-90|*|,MD756463486|*|32.502281|*|-92.111987|*|608 Grammont Street|*|Monroe|*|71201|*|Louisiana|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-20.html|*||*|,LA756461035|*|39.1330978|*|-84.50013489999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-19.html|*|Suite 200|*|,OH762941694|*|35.4778057|*|-97.52234920000001|*|535 Northwest 9th Street|*|Oklahoma City|*|73102|*|Oklahoma|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-12-2.html|*|Suite 325|*|,OK756048237|*|29.114521|*|-81.0237998|*|1690 Dunlawton Avenue|*|Port Orange|*|32127|*|Florida|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-3.html|*|Suite 110|*|,FL756051799|*|26.5156471|*|-80.0911178|*|1325 South Congress Avenue|*|Boynton Beach|*|33426|*|Florida|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-5.html|*|Suite 211|*|,FL756458907|*|35.6800147|*|-80.47100089999998|*|410 Mocksville Avenue|*|Salisbury|*|28144|*|North Carolina|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-16.html|*||*|,NC756053662|*|42.3404428|*|-71.10499170000003|*|300 Brookline Avenue|*|Boston|*|02215|*|Massachusetts|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-8.html|*|Rabb/Rose 440|*|,MA756053114|*|40.7848037|*|-73.70848699999999|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-7.html|*|Suite 160|*|,NY756459471|*|35.8235901|*|-78.70586220000001|*|3100 Duraleigh Road|*|Raleigh|*|27612|*|North Carolina|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-17.html|*|Suite 304|*|,NC756468964|*|38.0360467|*|-78.45516700000002|*|325 Winding River Lane|*|Charlottesville|*|22911|*|Virginia|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-23.html|*|Suite 102|*|,VA756054500|*|36.1424123|*|-86.80044229999999|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-9.html|*|103C Medical Arts Building |*|,TN756052442|*|25.7886212|*|-80.21586430000002|*|1400 Northwest 12th Avenue|*|Miami|*|33136|*|Florida|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-6.html|*|GI Center 1st Floor|*|,FL756468343|*|42.0885944|*|-70.9884338|*|189 Quincy Street|*|Brockton|*|02302|*|Massachusetts|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-22.html|*||*|,MA756047011|*|44.0225485|*|-92.46666019999998|*|200 1st Street Southwest|*|Rochester|*|55902|*|Minnesota|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-2.html|*||*|,MN756458277|*|36.0774456|*|-80.2951251|*|1901 South Hawthorne Road|*|Winston-Salem|*|27103|*|North Carolina|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-15.html|*|Suite 306|*|,NC756454252|*|42.3475004|*|-71.5110919|*|488 Boston Post Road East|*|Marlborough|*|01752|*|Massachusetts|*|A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/seres/a-multiple-dose-study-to-11.html|*||*|,MA558738575|*|56.130366|*|-106.34677099999999|*||*||*||*||*|A Phase 1/2 Randomized, Placebo-Controlled, Double-Blind Study of the Induction of Clinical Response and Remission by QBECO Site Specific Immunomodulator (SSI) in Subjects With Moderate to Severe Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/qu-biologics/a-phase-12-randomized.html|*||*|,AK558741711|*|49.27850309999999|*|-123.12769930000002|*|1190 Hornby Street #770, Vancouver, BC V6Z 2K5, Canada|*|Vancouver|*|V6Z 2K5|*|BC|*|A Phase 1/2 Randomized, Placebo-Controlled, Double-Blind Study of the Induction of Clinical Response and Remission by QBECO Site Specific Immunomodulator (SSI) in Subjects With Moderate to Severe Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/qu-biologics/a-phase-12-randomized-1.html|*||*|814428695|*|32.5060195|*|-92.11385669999999|*|616 Washington Street|*|Monroe|*|71201|*|Louisiana|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-3.html|*||*|,LA814429239|*|39.2882391|*|-76.6248094|*|22 South Greene Street|*|Baltimore|*|21201|*|Maryland|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-4.html|*||*|,MD814429786|*|39.0776082|*|-77.4773088|*|19455 Deerfield Avenue|*|Lansdowne|*|20176|*|Virginia|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-5.html|*||*|,VA814431969|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-9.html|*||*|,FL814432401|*|30.5148405|*|-87.21974469999998|*|8333 North Davis Highway|*|Pensacola|*|32514|*|Florida|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-10.html|*||*|,FL814433115|*|32.9354834|*|-97.1084679|*|505 South Nolen Drive|*|Southlake|*|76092|*|Texas|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-11.html|*||*|,TX814430289|*|35.82359960000001|*|-78.70582379999996|*|3100 Duraleigh Road|*|Raleigh|*|27612|*|North Carolina|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-6.html|*||*|,NC814433973|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-13.html|*||*|,TX814430862|*|40.8853859|*|-111.86657730000002|*|425 Medical Drive|*|Bountiful|*|84010|*|Utah|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-7.html|*||*|,UT814428048|*|32.748867|*|-97.11962199999999|*|1009 Magnolia Street|*|Arlington|*|76012|*|Texas|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-2.html|*||*|,TX814433607|*|36.0713656|*|-115.27769519999998|*|8530 West Sunset Road|*|Las Vegas|*|89113|*|Nevada|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-12.html|*||*|,NV814427234|*|32.4438631|*|-93.71252170000002|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-1.html|*||*|,LA814431509|*|29.8517136|*|-97.94548789999999|*|1305 Wonder World Drive|*|San Marcos|*|78666|*|Texas|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4016/a-phase-2-double-blind-1-8.html|*||*|,TX814415120|*|32.4438631|*|-93.71252170000002|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-2.html|*||*|,LA814422525|*|35.82359960000001|*|-78.70582379999996|*|3100 Duraleigh Road|*|Raleigh|*|27612|*|North Carolina|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-8.html|*||*|,NC814423177|*|40.8853859|*|-111.86657730000002|*|425 Medical Drive|*|Bountiful|*|84010|*|Utah|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-9.html|*||*|,UT814424976|*|30.5148405|*|-87.21974469999998|*|8333 North Davis Highway|*|Pensacola|*|32514|*|Florida|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-12.html|*||*|,FL814416091|*|32.748867|*|-97.11962199999999|*|1009 Magnolia Street|*|Arlington|*|76012|*|Texas|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-3.html|*||*|,TX814424409|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-11.html|*||*|,FL814421796|*|39.0776082|*|-77.4773088|*|19455 Deerfield Avenue|*|Lansdowne|*|20176|*|Virginia|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-7.html|*||*|,VA814419395|*|39.6221207|*|-77.6838717|*|11110 Medical Campus Road|*|Hagerstown|*|21742|*|Maryland|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-5.html|*||*|,MD814423857|*|29.8517136|*|-97.94548789999999|*|1305 Wonder World Drive|*|San Marcos|*|78666|*|Texas|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-10.html|*||*|,TX814416990|*|27.8715336|*|-82.75297239999998|*|8250 Bryan Dairy Road|*|Largo|*|33777|*|Florida|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-4.html|*||*|,FL814421050|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-6.html|*||*|,MI814425528|*|32.9354834|*|-97.1084679|*|505 South Nolen Drive|*|Southlake|*|76092|*|Texas|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-13.html|*||*|,TX814425985|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-4015/a-phase-2-double-blind-14.html|*||*|,TN695588828|*|32.2536715|*|-110.88259490000002|*|2585 North Wyatt Drive|*|Tucson|*|85712|*|Arizona|*|A Phase 2, Multi-Center, Open-Label Induction Trial with Extension Period to Assess Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients with Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/2201/a-phase-2-multi-center-5.html|*||*|,AZ695583602|*|38.8150189|*|-94.52112449999998|*|108 Congress|*|Belton|*|64012|*|Missouri|*|A Phase 2, Multi-Center, Open-Label Induction Trial with Extension Period to Assess Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients with Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/2201/a-phase-2-multi-center-2.html|*||*|,MO695581944|*|32.8009664|*|-117.15244610000002|*|8008 Frost Street|*|San Diego|*|92123|*|California|*|A Phase 2, Multi-Center, Open-Label Induction Trial with Extension Period to Assess Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients with Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/2201/a-phase-2-multi-center-1.html|*|Suite 200|*|,CA695590022|*|33.537975|*|-80.82602199999997|*|1131 Cook Road|*|Orangeburg|*|29118|*|South Carolina|*|A Phase 2, Multi-Center, Open-Label Induction Trial with Extension Period to Assess Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients with Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/2201/a-phase-2-multi-center-6.html|*||*|,SC695586564|*|38.9638599|*|-77.0904731|*|5550 Friendship Boulevard|*|Chevy Chase|*|20815|*|Maryland|*|A Phase 2, Multi-Center, Open-Label Induction Trial with Extension Period to Assess Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients with Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/2201/a-phase-2-multi-center-4.html|*|Suite T90|*|,MD695591832|*|29.5181406|*|-98.5677584|*|8550 Datapoint Drive|*|San Antonio|*|78229|*|Texas|*|A Phase 2, Multi-Center, Open-Label Induction Trial with Extension Period to Assess Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients with Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/2201/a-phase-2-multi-center-8.html|*|Suite 230|*|,TX695584952|*|28.2544921|*|-82.18651640000002|*|38135 Market Square|*|Zephyrhills|*|33542|*|Florida|*|A Phase 2, Multi-Center, Open-Label Induction Trial with Extension Period to Assess Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients with Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/2201/a-phase-2-multi-center-3.html|*||*|,FL695590865|*|33.9701743|*|-84.54791620000003|*|711 Canton Road|*|Marietta|*|30060|*|Georgia|*|A Phase 2, Multi-Center, Open-Label Induction Trial with Extension Period to Assess Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients with Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/2201/a-phase-2-multi-center-7.html|*|Suite 300|*|,GA752802500|*|39.138644|*|-84.5039261|*|231 Albert Sabin Way|*|Cincinnati|*|45229|*|Ohio|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-16.html|*|MSB|*|,OH752793364|*|47.6094749|*|-122.32790779999999|*|1100 9th Avenue|*|Seattle|*|98101|*|Washington|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-3.html|*|M.S. C2-HEM|*|,WA752794289|*|35.8235901|*|-78.70586220000001|*|3100 Duraleigh Road|*|Raleigh|*|27612|*|North Carolina|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-2-1.html|*|Suite 304|*|,NC752797119|*|29.114521|*|-81.0237998|*|1690 Dunlawton Avenue|*|Port Orange|*|32127|*|Florida|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-9.html|*|Ste 110|*|,FL752795036|*|42.5891846|*|-83.16958190000003|*|4550 Investment Drive|*|Troy|*|48098|*|Michigan|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-4.html|*|Ste 260|*|,MI752798569|*|26.0204249|*|-80.17921130000002|*|1150 North 35th Avenue|*|Hollywood|*|33021|*|Florida|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-11.html|*|Ste 445|*|,FL752791461|*|42.0532391|*|-88.14110790000001|*|1555 Barrington Road|*|Hoffman Estates|*|60169|*|Illinois|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-1.html|*|2300B|*|,IL752801946|*|31.2231436|*|-85.43547719999998|*|480 Honeysuckle Road|*|Dothan|*|36305|*|Alabama|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-15.html|*||*|,AL752800297|*|36.180803|*|-86.60785799999996|*|5653 Frist Boulevard|*|Nashville|*|37076|*|Tennessee|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-12.html|*|Suite 730|*|,TN752801623|*|26.2417382|*|-81.78843640000002|*|Goodlette-Frank Road|*|North Naples|*||*|Florida|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-14.html|*||*|,FL752796682|*|38.9627213|*|-77.08895059999998|*|Friendship Boulevard|*|Chevy Chase|*|20815|*|Maryland|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-8.html|*|Suite T90|*|,MD752797406|*|43.0660277|*|-88.04858030000003|*|2645 North Mayfair Road|*|Wauwatosa|*|53226|*|Wisconsin|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-10.html|*|Suite 200|*|,WI752795923|*|39.7685402|*|-105.08418599999999|*|7760 West 38th Avenue|*|Wheat Ridge|*|80033|*|Colorado|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-6.html|*|Suite 100|*|,CO752796138|*|40.1178595|*|-88.21384189999998|*|611 West Park Street|*|Urbana|*|61801|*|Illinois|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-7.html|*|DHC T1|*|,IL752795446|*|25.7868239|*|-80.36924899999997|*|1414 Northwest 107th Avenue|*|Doral|*|33172|*|Florida|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-5.html|*|Suite 214|*|,FL752800744|*|41.1542481|*|-111.94184439999998|*|5896 South Ridgeline Drive|*|South Ogden|*|84405|*|Utah|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-13.html|*|Suite A|*|,UT752802808|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-17.html|*||*|,TN752792332|*|35.8235901|*|-78.70586220000001|*|3100 Duraleigh Road|*|Raleigh|*|27612|*|North Carolina|*|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mmg/a-phase-2-randomized-2.html|*|Suite 304|*|,NC658978172|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-1.html|*|4001 Preston Avenue, Suite 125|*|,TX658985154|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-4.html|*|1325 South Congress Avenue Suite 111|*|,FL658996243|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-16.html|*|480 Honeysuckle Road|*|,AL658988958|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-10.html|*|7200 Northwest 7th Street Suite 350|*|,FL658987469|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-7.html|*|1000 Northern Boulevard Suite 160|*|,NY658993994|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-13.html|*|627 South Preston Street Med-Dent Complex, Suite 400|*|,KY658994447|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-14.html|*|8110 Airport Boulevard|*|,CA658986234|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-5.html|*|30795 23 Mile Road Suite 206|*|,MI658994957|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-15.html|*|4550 Investment Drive, Ste 260|*|,MI658970266|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized.html|*||*|658993337|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-12.html|*|39 Brewster Road|*|,CT658984079|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-3.html|*|5758 South Maryland Avenue DCAM 0301, MC 9028|*|,IL658988548|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-9.html|*|4700 North State Road 7 Building A, Suite 111|*|,FL658998425|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-19.html|*|1200 Main Street West Room HSC 3N51 Hamilton, Ontario L8N 3Z5|*|658990945|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-11.html|*|30 N 1900 E Room 4R118 SOM|*|,UT658987819|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-8.html|*|1959 Northeast Pacific Street Suite AA103 UW BOX 356424|*|,WA658986806|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-6.html|*|860 Peachwood Drive|*|,FL658997268|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-18.html|*|University of Manitoba 820 Sherbrook Street Winnepeg, Manitoba R3A 1R9|*|658996771|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-17.html|*|1421 North State Street Suite 203|*|,MS658982235|*||*||*||*||*||*||*|A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of apremilast (CC-10004) for treatment of subjects with active ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/Apremilast/a-phase-2-randomized-2.html|*|2925 Vernon Place, Suite 200|*|,OH798340339|*|41.7185303|*|-73.9295012|*|243 North Road|*|Poughkeepsie|*|12601|*|New York|*|A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN-LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (TUSCANY STUDY B7541002)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7541002/a-phase-2a-multicenter-7.html|*|Suite 304|*|,NY769071467|*|40.7848037|*|-73.70848699999999|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN-LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (TUSCANY STUDY B7541002)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7541002/a-phase-2a-multicenter-4.html|*|Suite 160|*|,NY813223960|*|40.7660738|*|-73.95501680000001|*|1315 York Avenue|*|New York|*|10021|*|New York|*|A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN-LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (TUSCANY STUDY B7541002)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7541002/a-phase-2a-multicenter-9.html|*||*|,NY759507302|*|42.0885944|*|-70.9884338|*|189 Quincy Street|*|Brockton|*|02302|*|Massachusetts|*|A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN-LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (TUSCANY STUDY B7541002)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7541002/a-phase-2a-multicenter-3.html|*||*|,MA813223615|*|40.7660738|*|-73.95501680000001|*|1315 York Avenue|*|New York|*|10021|*|New York|*|A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN-LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (TUSCANY STUDY B7541002)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7541002/a-phase-2a-multicenter-8.html|*||*|,NY759506345|*|25.9722135|*|-80.29907600000001|*|11460 Interchange Circle North|*|Miramar|*|33025|*|Florida|*|A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN-LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (TUSCANY STUDY B7541002)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7541002/a-phase-2a-multicenter-2.html|*||*|,FL797546575|*|36.142512|*|-86.80046440000001|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN-LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (TUSCANY STUDY B7541002)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7541002/a-phase-2a-multicenter-6-1.html|*||*|,TN815424178|*|34.05572|*|-118.27157499999998|*|1636 Wilshire Boulevard|*|Los Angeles|*|90017|*|California|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-3.html|*||*|,CA815428212|*|32.4843733|*|-93.77536559999999|*|3217 Mabel Street|*|Shreveport|*|71103|*|Louisiana|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-10.html|*||*|,LA815428657|*|30.2894017|*|-81.60278140000003|*|3550 University Boulevard South|*|Jacksonville|*|32216|*|Florida|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-11.html|*||*|,FL815423067|*|33.9850153|*|-83.41602519999998|*|3320 Old Jefferson Road|*|Athens|*|30607|*|Georgia|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-2.html|*||*|,GA815430094|*|32.6458934|*|-96.88031460000002|*|951 York Drive|*|DeSoto|*|75115|*|Texas|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-14.html|*||*|,TX815430400|*|39.1330793|*|-84.50014779999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-15.html|*||*|,OH815430838|*|25.7817507|*|-80.31304190000003|*|1150 Northwest 72nd Avenue|*|Miami|*|33126|*|Florida|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-16.html|*||*|,FL815427242|*|37.4978455|*|-77.46685400000001|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|Virginia|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-9.html|*||*|,VA815426313|*|36.1767261|*|-86.6077153|*|5653 Frist Boulevard|*|Nashville|*|37076|*|Tennessee|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-7.html|*||*|,TN815429060|*|25.7868239|*|-80.36924899999997|*|1414 Northwest 107th Avenue|*|Doral|*|33172|*|Florida|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-12.html|*||*|,FL815425778|*|29.11452109999999|*|-81.0237998|*|1690 Dunlawton Avenue|*|Port Orange|*|32127|*|Florida|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-6.html|*||*|,FL818180128|*|40.7848037|*|-73.70848699999999|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-17.html|*||*|,NY815424663|*|34.05572|*|-118.27157499999998|*|1636 Wilshire Boulevard|*|Los Angeles|*|90017|*|California|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-4.html|*||*|,CA815429812|*|38.9639621|*|-77.0904337|*|5550 Friendship Boulevard|*|Chevy Chase|*|20815|*|Maryland|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-13.html|*||*|,MD815426766|*|34.0701958|*|-84.17311699999999|*|4395 Johns Creek Parkway|*|Suwanee|*|30024|*|Georgia|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-8.html|*||*|,GA815425162|*|33.9699053|*|-84.54822760000002|*|711 Canton Road Northeast|*|Marietta|*|30060|*|Georgia|*|A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel Adaptive 2-stage, Multi-center Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects with Moderate to Severe Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/protagonist/a-phase-2b-randomized-5.html|*||*|,GA813951769|*|29.7296586|*|-95.41090780000002|*|4100 South Shepherd Drive|*|Houston|*|77098|*|Texas|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-8.html|*||*|,TX817043985|*|25.7871071|*|-80.21295989999999|*|1120 Northwest 14th Street|*|Miami|*|33136|*|Florida|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-13.html|*||*|,FL817043643|*|39.1790459|*|-76.84548010000003|*|7120 Minstrel Way|*|Columbia|*|21045|*|Maryland|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-12.html|*||*|,MD796657703|*|41.675724|*|-72.9360251|*|41 Brewster Road|*|Bristol|*|06010|*|Connecticut|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-5.html|*||*|,CT796657189|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-4.html|*||*|,TN817043200|*|42.5891846|*|-83.16958190000003|*|4550 Investment Drive|*|Troy|*|48098|*|Michigan|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-11.html|*||*|,MI817042632|*|29.7296586|*|-95.41090780000002|*|4100 South Shepherd Drive|*|Houston|*|77098|*|Texas|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-10.html|*||*|,TX819566104|*|32.937834|*|-97.11329510000002|*|2485 East Southlake Boulevard|*|Southlake|*|76092|*|Texas|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-14.html|*||*|,TX796658424|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-6.html|*||*|,OH796656870|*|38.963962|*|-77.09043329999997|*|5550 Friendship Boulevard|*|Chevy Chase|*|20815|*|Maryland|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-3.html|*|#T90|*|,MD796656021|*|32.4450324|*|-93.70582279999996|*|East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (VIBRATO STUDY B7981005)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pfizer/b7981005/a-phase-2b-double-blind-2.html|*||*|,LA767604273|*|39.6928775|*|-84.09636539999997|*|75 Sylvania Drive|*|Dayton|*|45440|*|Ohio|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-19.html|*||*|,OH767607448|*|33.3876011|*|-111.8762944|*|1500 South Dobson Road|*|Mesa|*|85202|*|Arizona|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-27.html|*|Suite 202|*|,AZ767606906|*|28.5979386|*|-81.35830290000001|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|Florida|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-25.html|*||*|,FL767515519|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-11.html|*|Suite 206|*|,MI767602423|*|39.739686|*|-105.07482829999998|*|7000 West Colfax Avenue|*|Lakewood|*|80214|*|Colorado|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-16.html|*||*|,CO767608424|*|33.9096523|*|-84.3502722|*|5671 Peachtree Dunwoody Road|*|Atlanta|*|30342|*|Georgia|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-30.html|*|Suite 512|*|,GA767513074|*|30.4160014|*|-91.08602300000001|*|9103 Jefferson Highway|*|Baton Rouge|*|70809|*|Louisiana|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-7.html|*|2nd Floor Research|*|,LA767512051|*|39.054213|*|-95.69233400000002|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-5.html|*||*|,KS767606630|*|32.8326258|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-24.html|*|suite 204|*|,GA767512722|*|28.2544921|*|-82.18651640000002|*|38135 Market Square|*|Zephyrhills|*|33542|*|Florida|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-6.html|*|Research Department|*|,FL767604738|*|34.7410417|*|-92.344311|*|6209 West 12th Street|*|Little Rock|*|72204|*|Arkansas|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-20.html|*||*|,AR767600954|*|38.9638736|*|-77.09046269999999|*|5550 Friendship Boulevard|*|Chevy Chase|*|20815|*|Maryland|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-13.html|*|Suite T-90|*|,MD767607862|*|36.1462944|*|-95.96679|*|1145 South Utica Avenue|*|Tulsa|*|74104|*|Oklahoma|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-28.html|*|Suite 514|*|,OK767514061|*|42.8601928|*|-85.71584100000001|*|2093 Health Drive Southwest|*|Wyoming|*|49519|*|Michigan|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-9.html|*|Suite 201|*|,MI767605513|*|26.1594033|*|-81.7911042|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-21.html|*||*|,FL767601884|*|43.0660277|*|-88.04858030000003|*|2645 North Mayfair Road|*|Wauwatosa|*|53226|*|Wisconsin|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-15.html|*|Suite 200|*|,WI767510898|*|30.2024457|*|-92.0195301|*|1214 Coolidge Street|*|Lafayette|*|70503|*|Louisiana|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-3.html|*||*|,LA767606336|*|34.0701958|*|-84.17311699999999|*|4395 Johns Creek Parkway|*|Suwanee|*|30024|*|Georgia|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-23.html|*|Suite 130|*|,GA767605776|*|40.6996178|*|-84.15028910000001|*|2793 Shawnee Road|*|Lima|*|45806|*|Ohio|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-22.html|*||*|,OH767603865|*|39.38348939999999|*|-74.57429769999999|*|3205 Fire Road|*|Egg Harbor Township|*|08234|*|New Jersey|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-18.html|*||*|,NJ767601617|*|28.831933|*|-82.33498100000003|*|411 West Highland Boulevard|*|Inverness|*|34452|*|Florida|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-14.html|*||*|,FL767607219|*|26.147599|*|-80.26005020000002|*|8200 West Sunrise Boulevard|*|Plantation|*|33322|*|Florida|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-26.html|*|Sutie D3|*|,FL767513751|*|47.6094749|*|-122.32790779999999|*|1100 9th Avenue|*|Seattle|*|98101|*|Washington|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-8.html|*||*|,WA767602516|*|39.0220576|*|-84.56070449999999|*|425 Centre View Boulevard|*|Crestview Hills|*|41017|*|Kentucky|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-17.html|*||*|,KY767510350|*|32.4254871|*|-93.71750609999998|*|1453 East Bert Kouns Industrial Loop|*|Shreveport|*|71105|*|Louisiana|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-2.html|*|Suite 318|*|,LA767608664|*|35.1099334|*|-89.79656460000001|*|1310 Wolf Park Road|*|Germantown|*|38138|*|Tennessee|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-31.html|*||*|,TN767515827|*|41.3767488|*|-72.90484049999998|*|2200 Whitney Avenue|*|Hamden|*|06518|*|Connecticut|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-12.html|*|Suite 360|*|,CT767608065|*|43.4728257|*|-111.98917849999998|*|2770 Cortez Avenue|*|Idaho Falls|*|83404|*|Idaho|*|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3031/a-phase-3-randomized-29.html|*||*|,ID799634981|*|34.7847708|*|-92.22020359999999|*|3401 Springhill Drive|*|North Little Rock|*|72117|*|Arkansas|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-21-1.html|*|Suite 400|*|,AR700321322|*|49.8470105|*|-99.942901|*|339 Princess Avenue|*|Brandon|*|R7A 0N7|*|Manitoba|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-7.html|*||*|700322456|*|38.2481197|*|-85.74672140000001|*|401 East Chestnut Street|*|Louisville|*|40202|*|Kentucky|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-8.html|*|Suite 400|*|,KY705528106|*|32.7910016|*|-96.77972460000001|*|3600 Gaston Avenue|*|Dallas|*|75246|*|Texas|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-24.html|*|Barnett Tower, Suite 507|*|,TX705438940|*|38.677806|*|-90.49721599999998|*|7 The Pines Court|*|St. Louis|*|63141|*|Missouri|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-23.html|*|Suite D|*|,MO799632368|*|43.7544445|*|-79.52584360000003|*|2111 Finch Avenue West|*|Toronto|*|M3N 1N1|*|Ontario|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-6-1.html|*||*|700365189|*|25.599214|*|-80.34842989999999|*|18320 Franjo Road|*|Miami|*|33157|*|Florida|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-17.html|*||*|,FL700324560|*|41.3767571|*|-72.9048113|*|2200 Whitney Avenue|*|Hamden|*|06518|*|Connecticut|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-10.html|*|Suite 360|*|,CT700316667|*|39.054213|*|-95.69233400000002|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-2.html|*||*|,KS700323383|*|28.2544921|*|-82.18651640000002|*|38135 Market Square|*|Zephyrhills|*|33542|*|Florida|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-9.html|*||*|,FL799631437|*|38.8150189|*|-94.52112449999998|*|108 Congress|*|Belton|*|64012|*|Missouri|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-4-1.html|*||*|,MO705436517|*|38.677806|*|-90.49721599999998|*|7 The Pines Court|*|St. Louis|*|63141|*|Missouri|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-22.html|*|Suite D|*|,MO700363160|*|44.0225485|*|-92.46666019999998|*|200 1st Street Southwest|*|Rochester|*|55902|*|Minnesota|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-14.html|*||*|,MN799631005|*|32.8009664|*|-117.15244610000002|*|8008 Frost Street|*|San Diego|*|92123|*|California|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-3-1.html|*|Suite 200|*|,CA700348021|*|40.7848073|*|-73.7086352|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-13.html|*|Suite 160|*|,NY705897853|*|29.5133369|*|-98.59123520000003|*|2833 Babcock Road|*|San Antonio|*|78229|*|Texas|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-25.html|*|Ste. 100|*|,TX799634423|*|36.8660121|*|-76.02983589999997|*|1101 First Colonial Road|*|Virginia Beach|*|23454|*|Virginia|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-18-1.html|*|Suite 300|*|,VA700310149|*|41.7114671|*|-87.77649180000003|*|9921 Southwest Highway|*|Oak Lawn|*|60453|*|Illinois|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-1.html|*||*|,IL700327276|*|35.5877405|*|-82.55223339999998|*|191 Biltmore Avenue|*|Asheville|*|28801|*|North Carolina|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-11.html|*||*|,NC700319523|*|28.260524|*|-82.706883|*|7114 Congress Street|*|New Port Richey|*|34653|*|Florida|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-5.html|*||*|,FL751919121|*|40.7331991|*|-73.9816083|*|350 East 17th Street|*|New York|*|10003|*|New York|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-27.html|*|3BH|*|,NY799634701|*|25.7493928|*|-80.32230429999998|*|7815 Coral Way|*|Miami|*|33155|*|Florida|*|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/receptos/3101/a-phase-3-multicenter-19-1.html|*|Suite 101|*|,FL529955281|*|33.7943893|*|-84.3188515|*|1760 Haygood Drive Northeast, Emory University, Atlanta, GA 30322, USA|*|Atlanta|*|30322|*|GA|*|A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/emory-msc/emory-msc-1.html|*||*|,GA529923557|*||*||*||*||*||*||*|A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/emory-msc/emory-msc.html|*||*|,GA630261471|*|32.3299426|*|-95.2895198|*|1720 South Beckham Avenue, Tyler, TX 75701, USA|*|Tyler|*|75701|*|TX|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-10.html|*||*|,TX631003756|*|26.1593354|*|-81.79095589999997|*|1064 Goodlette Road North, Naples, FL 34102, USA|*|Naples|*|34102|*|FL|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-37.html|*||*|,FL630880283|*|31.7706384|*|-106.43444669999997|*|4800 Alameda Avenue, El Paso, TX 79905, USA|*|El Paso|*|79905|*|TX|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-32.html|*||*|,TX630453656|*|39.158509|*|-91.87676699999997|*|714 Medical Park Drive, Mexico, MO 65265, USA|*|Mexico|*|65265|*|MO|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-20.html|*||*|,MO631025336|*|39.264767|*|-84.33746810000002|*|8271 Cornell Road #730, Cincinnati, OH 45249, USA|*|Cincinnati|*|45249|*|OH|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-44.html|*||*|,OH630880810|*|33.9174738|*|-117.99825670000001|*|15627 Imperial Highway, La Mirada, CA 90638, USA|*|La Mirada|*|90638|*|CA|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-33.html|*||*|,CA630681483|*|34.2592672|*|-119.20899209999999|*|1746 South Victoria Avenue #230, Ventura, CA 93003, USA|*|Ventura|*|93003|*|CA|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-24.html|*||*|,CA630247276|*|38.8119527|*|-94.5318982|*||*|Belton|*||*|MO|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-7.html|*||*|,MO630263492|*|29.6507336|*|-95.1700702|*|4001 Preston Road #125, Pasadena, TX 77505, USA|*|Pasadena|*|77505|*|TX|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-12.html|*||*|,TX630256359|*|34.7480609|*|-92.34293509999998|*|500 South University Avenue #500, Little Rock, AR 72205, USA|*|Little Rock|*|72205|*|AR|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-9.html|*||*|,AR630486448|*|38.9638599|*|-77.0904731|*|5550 Friendship Boulevard, Chevy Chase, MD 20815, USA|*|Chevy Chase|*|20815|*|MD|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-22.html|*||*|,MD630246004|*|42.8602173|*|-85.71581930000002|*|2093 Health Drive Southwest, Wyoming, MI 49519, USA|*|Wyoming|*|49519|*|MI|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-6.html|*||*|,MI630684581|*|35.0537002|*|-85.182072|*|6035 Shallowford Road #109, Chattanooga, TN 37421, USA|*|Chattanooga|*|37421|*|TN|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-27.html|*||*|,TN631006215|*|39.1330793|*|-84.50014779999998|*|2925 Vernon Place, Cincinnati, OH 45219, USA|*|Cincinnati|*|45219|*|OH|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-39.html|*||*|,OH630877224|*|41.611037|*|-93.74493689999997|*|2024 Northwest 92nd Court #8, Clive, IA 50325, USA|*|Clive|*|50325|*|IA|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-29.html|*||*|,IA630875887|*|29.460453|*|-98.41782439999997|*|3551 Roger Brooke Drive, San Antonio, TX 78219, USA|*|San Antonio|*|78219|*|TX|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-28.html|*||*|,TX630877698|*|37.5009776|*|-122.25492459999998|*|1000 Laurel Street, San Carlos, CA 94070, USA|*|San Carlos|*|94070|*|CA|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-30.html|*||*|,CA631007594|*|34.0702074|*|-84.17299349999996|*|4395 Johns Creek Parkway #130, Suwanee, GA 30024, USA|*|Suwanee|*|30024|*|GA|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-40.html|*||*|,GA630681968|*|29.114485|*|-81.023956|*|1690 Dunlawton Avenue #110, Port Orange, FL 32127, USA|*|Port Orange|*|32127|*|FL|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-25.html|*||*|,FL631015539|*|26.184379|*|-80.20152300000001|*|4700 N State Road|*|Lauderdale Lakes|*|33319|*|Florida|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-41.html|*||*|,FL630209390|*|38.6013834|*|-121.39313700000002|*|2025 Morse Avenue, Sacramento, CA 95825, USA|*|Sacramento|*|95825|*|CA|*|A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease |*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/red-hill-2/a-phase-iii-randomized-1.html|*||*|,CA340011407|*|33.944647|*|-84.3226488|*||*|Atlanta|*|30338|*|GA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-GA-2.html|*||*|,GA340011253|*|26.0197012|*|-80.1819268|*||*|Hollywood|*|33021|*|FL|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-FL-9.html|*||*|,FL340012570|*|37.3466983|*|-79.2112769|*||*|Lynchburg|*|24502|*|VA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-VA-1.html|*||*|,VA512148384|*|41.4305881|*|-72.9106202|*||*|Hamden|*|06518|*|CT|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/sponsor-profiles/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-CT-1.html|*||*|,CT340011439|*|34.0514898|*|-84.0712997|*||*|Suwanee|*||*|GA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-GA-4.html|*||*|,GA340011124|*|27.8580624|*|-82.7616822|*||*|Seminole|*|33777|*|FL|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-FL-1.html|*||*|,FL340011055|*|39.6696322|*|-104.9330448|*||*|Denver|*|80222|*|CO|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-CO-1.html|*||*|,CO340011082|*|41.4305881|*|-72.9106202|*||*|Hamden|*|06518|*|CT|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-CT-1.html|*||*|,CT340012585|*|36.7578013|*|-76.2131474|*||*|Chesapeake|*|23320|*|VA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-VA-2.html|*||*|,VA340010885|*|34.7486563|*|-92.3542193|*||*|Little Rock|*|72205|*|AR|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-AR-3.html|*||*|,AR340011000|*|32.6385134|*|-117.0617553|*||*|Chula Vista|*|91910|*|CA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-CA-5.html|*||*|,CA660634322|*||*||*||*||*||*||*|A Pilot Study Investigating a Decentralized Approach to Studying Dietary Intervention in Patients With Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/transparancy-ls/a-pilot-study-investigating-a-1.html|*|850 Boylston Street|*|,MA657358706|*||*||*||*||*||*||*|A Pilot Study Investigating a Decentralized Approach to Studying Dietary Intervention in Patients With Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/transparancy-ls/a-pilot-study-investigating-a.html|*||*|,MA657367104|*|49.27850309999999|*|-123.12769930000002|*|1190 Hornby Street|*|Vancouver|*|V6Z 2K5|*|British Columbia|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-19.html|*||*|,WI657365948|*|32.935516|*|-97.10844399999996|*|505 South Nolen Drive, Southlake, TX 76092, USA|*|Southlake|*|76092|*|TX|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-16.html|*||*|,TX640703674|*|41.5076487|*|-81.60587179999999|*|11100 Euclid Avenue|*|Cleveland|*|44106|*|Ohio|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-5.html|*|Mail Stop WRN 5066|*|,OH657365277|*|32.8009664|*|-117.15244610000002|*|8008 Frost Street|*|San Diego|*|92123|*|California|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-15.html|*|Suite 200|*|,MI,OH,VA,FL,CA,KY,NY640707296|*|40.7424757|*|-73.9788332|*|232 East 30th Street|*|New York|*|10016|*|New York|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-9.html|*||*|,NY657366647|*|36.0800225|*|-86.71695139999997|*|330 Wallace Road|*|Nashville|*|37211|*|Tennessee|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-18.html|*|Suite 103|*|,TN657366304|*|35.039825|*|-78.91015600000003|*|2109 Valleygate Drive|*|Fayetteville|*|28304|*|North Carolina|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-17.html|*|Suite 102|*|,NC640702447|*|40.78998989999999|*|-73.95369089999997|*|1 Gustave L. Levy Place|*|New York|*|10029|*|New York|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-4.html|*|Box 1118|*|,NY640704767|*|43.1927271|*|-77.58679810000001|*|1425 Portland Avenue|*|Rochester|*|14621|*|New York|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-7.html|*||*|,NY640701269|*|34.0749524|*|-118.38248040000002|*|8730 Alden Drive|*|Los Angeles|*|90048|*|California|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-2.html|*|W203|*|,CA640635600|*|37.7854864|*|-122.44022230000002|*|1701 Divisadero Street|*|San Francisco|*|94115|*|California|*|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/celgene-ged-0301/a-randomized-double-blind-1.html|*|Suite 120|*|,CA449188417|*|37.49646|*|-77.465839|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|VA|*|A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA-001) for the Treatment of Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/va.html|*||*|,VA452031417|*|43.192443|*|-77.5858998|*|1425 Portland Avenue|*|Rochester|*|14621|*|NY|*|A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA-001) for the Treatment of Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/ny.html|*||*|,NY448125004|*|39.742571|*|-104.8394653|*|1635 Aurora Court|*|Aurora|*|80045|*|CO|*|A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA-001) for the Treatment of Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/co.html|*||*|,CO453797151|*|29.709906|*|-95.40283|*|6620 Main Street #1225|*|Houston|*|77030|*|TX|*|A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA-001) for the Treatment of Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/tx.html|*||*|,TX456674095|*|40.7697274|*|-111.8379664|*|30 North 1900 East|*|Salt Lake City|*|84132|*|UT|*|A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA-001) for the Treatment of Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/ut.html|*||*|,UT447280848|*|29.633344|*|-82.338476|*|2001 Southwest 13th Street|*|Gainesville|*|32608|*|FL|*|A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA-001) for the Treatment of Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/fl.html|*||*|,FL447280902|*|41.5072304|*|-81.6071674|*|11100 Euclid Avenue|*|Cleveland|*|44106|*|OH|*|A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA-001) for the Treatment of Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pda-study/oh.html|*||*|,OH732019762|*|44.0225485|*|-92.46666019999998|*|200 1st Street Southwest|*|Rochester|*|55902|*|Minnesota|*|A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects with Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis |*|,ulcerative-colitis,other|*|,adult-18|*|,female,male|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/atlantic/a-randomised-double-blind-1.html|*||*|,MN453869583|*|41.7118696|*|-87.77707|*|9921 Southwest Highway|*|Oak Lawn|*|60453|*|IL|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1139-il.html|*||*|,IL454057147|*|42.9911995|*|-87.9495579|*|2801 West Kinnickinnic River Parkway #1030|*|Milwaukee|*|53215|*|WI|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1049-wi.html|*||*|,WI454057159|*|36.8530726|*|-76.1939191|*|885 Kempsville Road #114|*|Norfolk|*|23502|*|VA|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1048-va.html|*||*|,VA454044937|*|29.639843|*|-82.3433853|*|1600 Southwest Archer Road|*|Gainesville|*|32603|*|FL|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1044-fl.html|*||*|,FL457284205|*|40.7697274|*|-111.8379664|*|30 North 1900 East|*|Salt Lake City|*|84132|*|UT|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1141-ut.html|*||*|,UT453871891|*|41.6825663|*|-81.2993753|*|9485 Mentor Avenue #105|*|Mentor|*|44060|*|OH|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1134-oh.html|*||*|,OH454057153|*|32.8328377|*|-83.6296556|*|610 3rd Street #204|*|Macon|*|31201|*|GA|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1060-ga.html|*||*|,GA453870393|*|32.330224|*|-95.289603|*|1720 South Beckham Avenue|*|Tyler|*|75701|*|TX|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1047-tx.html|*||*|,TX454057140|*|26.1593285|*|-81.7911031|*|1064 Goodlette Road North|*|Naples|*||*|FL|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1039-fl.html|*||*|,FL453871897|*|35.2085398|*|-80.8221182|*|2015 Randolph Road #101|*|Charlotte|*|28207|*|NC|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1043-nc.html|*||*|,NC454044944|*|42.676265|*|-82.804801|*|30795 23 Mile Road #206|*|Chesterfield|*|48047|*|MI|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1042-mi.html|*||*|,MI454059613|*|39.693185|*|-84.096461|*|75 Sylvania Road|*|Dayton|*|45440|*|OH|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1038-oh.html|*||*|,OH453870328|*|42.5882173|*|-83.1693749|*|4550 Investment Drive #260|*|Troy|*|48098|*|MI|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1133-mi.html|*||*|,MI454059607|*|41.718495|*|-73.929638|*|243 North Road #304|*|Poughkeepsie|*|12601|*|NY|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1132-ny.html|*||*|,NY454044929|*|28.2537576|*|-82.1852455|*|38135 Market Square|*|Zephyrhills|*|33542|*|FL|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1046-fl.html|*||*|,FL453870386|*|33.8193774|*|-117.9150117|*|1085 Harbor Boulevard|*|Anaheim|*|92805|*|CA|*|A randomized, double-blind, placebo-controlled, parallel group, multi-centre study to investigate the safety and efficacy of CP-690,550 for induction therapy in subjects with moderate to severe Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/octave/1045-ca.html|*||*|,CA387684807|*||*||*||*||*||*||*|A Study to Assess Effectiveness of Communication to Patients and Caregivers/Parents of Children with Moderately to Severely Active Ulcerative Colitis |*|,ulcerative-colitis|*|,adult-18,pediatric-under-18|*|,female,male|*||*|,national-study|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/communication-study.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY540223863|*|32.8766678|*|-117.22733970000002|*|9444 Medical Center Drive #2, University of California San Diego, La Jolla, CA 92037, USA|*|San Diego|*|92037|*|CA|*|A Study to Evaluate Prediction of Response to an Investigational Medication in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/janssen/a-study-to-evaluate-10.html|*||*|,VA,FL,GA,MN,MO,CA,CO340014510|*|38.963947|*|-77.089841|*|5550 Friendship Blvd|*|Chevy Chase|*|20815|*|MD|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MD-1.html|*||*|,MD340014825|*|35.229895|*|-97.441756|*|900 North Porter Avenue, Norman, OK 73071, USA|*|Norman|*|73071|*|OK|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-OK-1.html|*||*|,OK340014544|*|42.5882045|*|-83.1693778|*|4550 Investment Dr|*|Troy|*|48098|*|MI|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MI-1.html|*||*|,MI340014645|*|35.208552|*|-80.821922|*|2015 Randolph Rd|*|Charlotte|*|28207|*|NC|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NC-1.html|*||*|,NC340014669|*|35.8162672|*|-78.7071459|*|2601 Lake Dr|*|Raleigh|*|27607|*|NC|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NC-2.html|*||*|,NC488411054|*|41.718495|*|-73.92963800000001|*|243 North Road #304, Poughkeepsie, NY 12601, USA|*|Poughkeepsie|*|12601|*|NY|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1130.html|*||*|,NY340014326|*|34.0699775|*|-84.1723229|*|4395 Johns Creek Pkwy|*|Suwanee|*|30024|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-GA-1.html|*||*|,GA340015000|*|36.741709|*|-76.245979|*|112 Gainsborough Square|*|Chesapeake|*|23320|*|VA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-VA-1.html|*||*|,VA340014190|*|32.2327704|*|-110.8397441|*|7140 E Rosewood St|*|Tucson|*|85710|*|AZ|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-AZ.html|*||*|,AZ488411050|*|29.114485|*|-81.023956|*|1690 Dunlawton Avenue #220, Port Orange, FL 32127, USA|*|Port Orange|*|32127|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1129.html|*||*|,FL340014356|*|33.790891|*|-84.283258|*|2675 N Decatur Rd|*|Decatur|*|30033|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-GA-3.html|*||*|,GA340014226|*|32.726688|*|-117.16071|*|2001 4th Ave|*|San Diego|*|92101|*|CA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-CA-2.html|*||*|,CA340014899|*|32.979071|*|-80.063205|*|2671 Elms Plantation Blvd|*|Charleston|*|29406|*|SC|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-SC.html|*||*|,SC488411110|*|26.3558169|*|-80.20221900000001|*|9970 South Central Park Boulevard #101, Boca Raton, FL 33428, USA|*|Boca Raton|*|33428|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1122.html|*||*|,FL491244326|*|34.105094|*|-80.95194400000003|*|11 Gateway Corners Park, Columbia, SC 29203, USA|*|Columbia|*|29203|*|SC|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1126.html|*||*|,SC340014309|*|30.250598|*|-81.585323|*|4800 Belfort Rd|*|Jacksonville|*|32256|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-FL-4.html|*||*|,FL491244318|*|33.971208|*|-83.41052300000001|*|2350 Prince Avenue #8, Athens, GA 30606, USA|*|Athens|*|30606|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1128.html|*||*|,GA340014390|*|41.602158|*|-93.789019|*|1378 NW 124th St|*|Clive|*|50325|*|IA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-IA.html|*||*|,IA340014752|*|40.7851075|*|-73.7085555|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|NY|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NY-1.html|*||*|,NY340014439|*|39.022126|*|-84.560647|*|425 Centre View Blvd|*|Crestview Hills|*|41017|*|KY|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-KY-2.html|*||*|,KY340014454|*|30.4153528|*|-91.0865044|*|9103 Jefferson Hwy|*|Baton Rouge|*|70809|*|LA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-LA.html|*||*|,LA340014403|*|37.640618|*|-98.7212339|*|420 Country Club Rd|*|Pratt|*|67124|*|KS|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-KS.html|*||*|,KS340014241|*|39.5299488|*|-104.8716283|*|10103 RidgeGate Parkway|*|Lone Tree|*|80124|*|CO|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-CO.html|*||*|,CO488411097|*|39.054213|*|-95.69233400000002|*|720 Southwest Lane Street, Topeka, KS 66606, USA|*|Topeka|*|66606|*|KS|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1118.html|*||*|,KS340014262|*|26.1593351|*|-81.7909686|*|1064 Goodlette Road North|*|Naples|*|34102|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-FL-1.html|*||*|,FL488411106|*|43.4728376|*|-111.9892701|*|2770 Cortez Avenue, Idaho Falls, ID 83404, USA|*|Idaho Falls|*|83404|*|ID|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1125.html|*||*|,ID340014526|*|39.386024|*|-76.606981|*|7402 York Rd|*|Towson|*|21204|*|MD|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MD-2.html|*||*|,MD340014931|*|36.1286652|*|-86.8452282|*|4230 Harding Rd|*|Nashville|*|37205|*|TN|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TN-2.html|*||*|,TN340014563|*|42.676265|*|-82.804801|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|MI|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MI-2.html|*||*|,MI340014293|*|29.65445|*|-82.38871|*|4343 W Newberry Rd|*|Gainesville|*|32607|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-FL-3.html|*||*|,FL340014468|*|42.273476|*|-71.794016|*|25 Oak Avenue|*|Worcester|*|01605|*|MA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MA.html|*||*|,MA340014986|*|32.935516|*|-97.108444|*|505 South Nolen Drive|*|Southlake|*|76092|*|TX|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TX-3.html|*||*|,TX340014616|*|38.977058|*|-94.357611|*|3601 NE Ralph Powell Rd|*|Lee's Summit|*|64064|*|MO|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MO-3.html|*||*|,MO340014630|*|30.408083|*|-88.762772|*|3890 Bienville Boulevard|*|Ocean Springs|*|39564|*|MS|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MS.html|*||*|,MS488406642|*|41.6825663|*|-81.29937530000001|*|9485 Mentor Avenue #105, Mentor, OH 44060, USA|*|Mentor|*|44060|*|OH|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1117.html|*||*|,OH340014952|*|32.330224|*|-95.289603|*|1720 S Beckham Ave|*|Tyler|*|75701|*|TX|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TX-1.html|*||*|,TX437732837|*|42.262253|*|-83.654131|*|5300 Elliott Drive|*|Ypsilanti|*|48197|*|MI|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MI-3.html|*||*|,MI340014972|*|30.303823|*|-97.747891|*|1305 W 34th St|*|Austin|*|78705|*|TX|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TX-2.html|*||*|,TX442782776|*|32.232429|*|-110.840042|*|7140 East Rosewood Street|*|Tucson|*|85710|*|AZ|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-AZ-1.html|*||*|,AZ340014808|*|39.1330793|*|-84.5001478|*|2925 Vernon Pl|*|Cincinnati|*|45219|*|OH|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-OH-2.html|*||*|,OH340014277|*|28.598041|*|-81.358368|*|701 W Morse Blvd|*|Winter Park|*|32789|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-FL-2.html|*||*|,FL340014340|*|32.8328365|*|-83.6295729|*|610 3rd St|*|Macon|*|31201|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-GA-2.html|*||*|,GA340014373|*|33.909086|*|-84.350774|*|5671 Peachtree Dunwoody Rd NE|*|Atlanta|*|30342|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-GA-4.html|*||*|,GA340014598|*|39.158509|*|-91.876767|*|714 Medical Park Dr|*|Mexico|*|65265|*|MO|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MO-2.html|*||*|,MO340014689|*|39.8828|*|-74.9247|*|406 Lippincott Drive|*|Evesham Township|*|08053|*|NJ|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NJ-1.html|*||*|,NJ488411101|*|27.871556|*|-82.75307599999996|*|8250 Bryan Dairy Road #200, Seminole, FL 33777, USA|*|Seminole|*|33777|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-1123.html|*||*|,FL340014709|*|39.383257|*|-74.57416|*|3205 Fire Rd|*|Egg Harbor Township|*|08234|*|NJ|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NJ-2.html|*||*|,NJ417453340|*|47.628523|*|-122.329977|*|1100 Fairview Avenue North|*|Seattle|*|98109|*|WA|*|Allogeneic hematopoietic cell transplantation for patients with treatment-refractory Crohn’s Disease: A phase 2 study|*|,crohns-disease|*|,adult-18|*|,female,male|*|,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/allogeneic-transplant-study.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY655610369|*|39.054213|*|-95.69233400000002|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-2.html|*||*|,KS655769180|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-10.html|*|Suite A|*|,TN655773972|*||*||*||*||*||*||*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-13.html|*||*|,MI,MA,MS,MN,MT,MO,NV,NE,KS,KY,LA,MD,ME,ND,OH,OK,OR,PA,RI,SC,NH,NJ,NM,NY,NC,AK,AL,AZ,HI,ID,FL,GA,IN,IA,IL,CA,AR,DE,DC,CO,CT,AB,WA,VA,VT,UT,TX,TN,SD,WY,WI,WV655762458|*|41.7186995|*|-73.92955310000002|*|243 North Road|*|Poughkeepsie|*|12601|*|New York|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-5.html|*|Suite 304|*|,NY655766424|*|32.8326258|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-8.html|*|Suite 204|*|,GA655764836|*|34.0701865|*|-84.17308639999999|*|4395 Johns Creek Parkway|*|Suwanee|*|30024|*|Georgia|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-7.html|*|Suite 130|*|,GA655763974|*|28.6373981|*|-81.36448250000001|*|260 Lookout Place|*|Maitland|*|32751|*|Florida|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-6.html|*|Suite 201 & 207|*|,FL655574869|*||*||*||*||*||*||*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study.html|*||*|,OH,BC,FL,OK,GA,MO,KS,NY,TN,CT655601197|*|41.461833|*|-81.49282299999999|*|3619 Park East Drive|*|Beachwood|*|44122|*|Ohio|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-1.html|*|Suite 300|*|,OH655767875|*|36.1462944|*|-95.96679|*|1145 South Utica Avenue|*|Tulsa|*|74104|*|Oklahoma|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-9.html|*|Suite 807|*|,OK655760208|*|28.831933|*|-82.33498100000003|*|411 West Highland Boulevard|*|Inverness|*|34452|*|Florida|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-4.html|*||*|,FL655769762|*|41.3767571|*|-72.9048113|*|2200 Whitney Avenue|*|Hamden|*|06518|*|Connecticut|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-11.html|*|Suite 370|*|655752921|*|38.5060797|*|-90.380563|*|10012 Kennerly Road|*|St. Louis|*|63128|*|Missouri|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-3.html|*|Suite 101|*|,MO655770245|*|49.27850309999999|*|-123.12769930000002|*|1190 Hornby Street|*|Vancouver|*|V6Z 2K5|*|British Columbia|*|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/3028/an-open-label-phase-3b-study-12.html|*||*|786202035|*|25.7047115|*|-80.29235829999999|*|6141 Sunset Drive|*|South Miami|*|33143|*|Florida|*|An Open-Label, 2-Part, Multicenter, Post-marketing Study to Evaluate the Effect of Moderately or Severely Active Ulcerative Colitis or Crohn’s Disease on Cytochrome P-450 Enzyme Substrates Compared to Healthy Subjects and the Effect of Vedolizumab Treatment on Cytochrome P-450 Enzyme Substrates in Subjects With Ulcerative Colitis or Crohn’s Disease.|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/4002/an-open-label-2-part.html|*||*|,FL769913316|*|40.7890732|*|-74.46514489999998|*|100 Madison Avenue|*|Morristown|*|07960|*|New Jersey|*|An Open-Label, Multicenter, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/vedolizumab/an-open-label-multicenter-2.html|*||*|,NJ769915434|*|39.7440519|*|-104.8407085|*|12631 East 17th Avenue|*|Aurora|*|80045|*|Colorado|*|An Open-Label, Multicenter, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/vedolizumab/an-open-label-multicenter-4.html|*|MS B-146|*|,CO769915793|*|36.1424123|*|-86.80044229999999|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|An Open-Label, Multicenter, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/vedolizumab/an-open-label-multicenter-5.html|*|103C Medical Arts Building|*|,TN769916196|*|40.1178595|*|-88.21384189999998|*|611 West Park Street|*|Urbana|*|61801|*|Illinois|*|An Open-Label, Multicenter, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/vedolizumab/an-open-label-multicenter-6.html|*||*|,IL769914681|*|29.6991505|*|-95.3945731|*|7200 Cambridge Street|*|Houston|*|77030|*|Texas|*|An Open-Label, Multicenter, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/takeda/vedolizumab/an-open-label-multicenter-3.html|*|Suite A10.184|*|,TX625616647|*|39.00281|*|-77.1044354|*|10 Center Drive, Bethesda, MD 20814, USA|*|Bethesda|*|20814|*|MD|*|An Open-Label, Phase I/II Pilot Study to Assess the Safety and Tolerability of Bone Marrow Stromal Cell Infusion for the Treatment of Moderate-to-Severe Inflammatory Bowel Disease|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/nih/an-open-label-phase-iii.html|*||*|,MD449181950|*||*||*||*||*||*||*|Assessing Chronically Ill Youth’s Access to Education|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,other|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/illness-education.html|*||*|,MI,MA,MS,MN,MT,MO,NV,NE,KS,KY,LA,MD,ME,ND,OH,OK,OR,PA,RI,SC,NH,NJ,NM,NY,NC,AK,AL,AZ,HI,ID,FL,GA,IN,IA,IL,CA,AR,DE,DC,CO,CT,WA,VA,VT,UT,TX,TN,SD,WY,WI,WV340015043|*||*||*||*||*||*||*|Autoimmune/Inflammatory Diseases in Pregnancy Study|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,other|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/autoimmune-diseases-pregnancy-study.html|*||*|,MI,MA,MS,MN,MT,NV,NE,KS,KY,LA,MD,ME,ND,OH,OK,OR,PA,RI,SC,NH,NJ,NM,NY,NC,AK,AL,AZ,HI,ID,FL,GA,IN,IA,IL,CA,AR,DE,DC,CO,CT,WA,VA,VT,UT,TX,TN,SD,WY,WI,WV695607016|*|40.79164069999999|*|-73.94479939999997|*||*|10029|*|1425 Madison Avenue, Box 1498 Rooms 14-70, New York, NY 10029, USA+|*|NY|*|Bacterial Transmission In Utero and IBD Risk (The MECONIUM Study)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ccfa/bacterial-transmission-in.html|*||*|,NY796532441|*|38.2806408|*|-85.74614959999997|*|1035 Wall Street|*|Jeffersonville|*|47130|*|Indiana|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-20.html|*|Suite 104-C2 |*|,IN796531720|*|41.7114671|*|-87.77649180000003|*|9921 Southwest Highway|*|Oak Lawn|*|60453|*|Illinois|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-18.html|*||*|,IL796521406|*|28.3009298|*|-81.40842499999997|*|403 West Oak Street|*|Kissimmee|*|34741|*|Florida|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-13.html|*||*|,FL796515049|*|28.6373981|*|-81.36448250000001|*|260 Lookout Place|*|Maitland|*|32751|*|Florida|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-3.html|*|Suite 201 & 107|*|,FL796520307|*|25.7690523|*|-80.23934009999999|*|330 Southwest 27th Avenue|*|Miami|*|33135|*|Florida|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-10.html|*|Suite 701|*|,CA796520650|*|34.8540636|*|-82.32455720000002|*|200 Patewood Drive|*|Greenville|*|29615|*|South Carolina|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-11.html|*|Suite B 200|*|,SC796517895|*|35.0847771|*|-106.63530129999998|*|300 Oak Street Northeast|*|Albuquerque|*|87106|*|New Mexico|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-5.html|*||*|,NM796516738|*|38.780769|*|-90.36367039999999|*|637 Dunn Road|*|Hazelwood|*|63042|*|Missouri|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-4.html|*|Suite 135|*|,MO796532114|*|30.2507979|*|-81.5858493|*|4800 Belfort Road|*|Jacksonville|*|32256|*|Florida|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-19.html|*|Suite 301 |*|,FL796534300|*|33.7630166|*|-84.37145939999999|*|315 Boulevard Northeast|*|Atlanta|*|30312|*|Georgia|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-21.html|*|Suite 528 |*|,GA796519631|*|34.05572|*|-118.27157499999998|*|1636 Wilshire Boulevard|*|Los Angeles|*|90017|*|California|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-9.html|*|Ste. 200|*|,CA796521728|*|29.78998709999999|*|-95.56748809999999|*|1140 Business Center Drive|*|Houston|*|77043|*|Texas|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-14.html|*|Ste 240 |*|,TX796529883|*|35.5877405|*|-82.55223339999998|*|191 Biltmore Avenue|*|Asheville|*|28801|*|North Carolina|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-16.html|*||*|,NC796521063|*|29.5133369|*|-98.59123520000003|*|2833 Babcock Road|*|San Antonio|*|78229|*|Texas|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-12.html|*|Suite 100 |*|,TX795829172|*|41.894593|*|-87.62162990000002|*|201 East Huron Street|*|Chicago|*|60611|*|Illinois|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-2.html|*|Suite 12-738|*|,IL796518638|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-7.html|*|Suite 105|*|,OH796522402|*|32.9156666|*|-96.86831130000002|*|9 Medical Parkway|*|Farmers Branch|*|75234|*|Texas|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-15.html|*| #206 |*|,TX796518285|*|28.2604685|*|-82.70694070000002|*|7114 Congress Street|*|New Port Richey|*|34653|*|Florida|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-6.html|*||*|,FL796519167|*|40.4777124|*|-74.42565230000002|*|3 Rutgers Square|*|New Brunswick|*|08901|*|New Jersey|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-8.html|*|3rd Floor|*|,NJ796531319|*|29.7903198|*|-95.70455709999999|*|19255 Park Row Drive|*|Houston|*|77084|*|Texas|*|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boehringer-ingelheim/bi-695501-versus-humira-in-17.html|*|Ste. 205|*|,TX346515343|*||*||*||*||*||*||*|CCFA Partners - Patients helping patients|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,national-study|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ccfa-partners-patients-national.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY342563884|*|35.901785|*|-79.0535174|*||*||*||*||*|CCFA Partners - Patients helping patients|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,ccfa-partners|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/ccfa-partners-patients.html|*||*|,NC342343385|*|41.6569617|*|-91.5478736|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ia.html|*||*|,IA342343164|*|40.7738568|*|-73.9607231|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ny1.html|*||*|,NY342343359|*|29.6397981|*|-82.3433446|*|1600 SW Archer Rd|*|Gainesville|*|32603|*|FL|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_fl2.html|*||*|,FL342343276|*|41.8084946|*|-71.4117197|*|33 Staniford St|*|Providence|*|02905|*|RI|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ri3.html|*||*|,RI342343229|*|33.5857641|*|-111.7935598|*|13400 E Shea Blvd|*|Scottsdale|*|85259|*|AZ|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_az.html|*||*|,AZ342343042|*|41.843654|*|-71.414823|*|146 W River St|*|Providence|*|02904|*|RI|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ri1.html|*||*|,RI342343248|*|45.0244667|*|-93.4796711|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_mn2.html|*||*|,MN342342990|*|42.3584308|*|-71.0597732|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ma2.html|*||*|,MA342343136|*|41.8412068|*|-71.4154382|*|44 W River St|*|Providence|*|02904|*|RI|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ri2.html|*||*|,RI342343181|*|42.3588106|*|-71.1239582|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ma4.html|*||*|,MA342343099|*|43.6728744|*|-72.2722639|*|Medical Center Dr|*|Lebanon|*|03766|*|NH|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_nh.html|*||*|,NH342342971|*|42.336226|*|-71.072918|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ma1.html|*||*|,MA342343442|*|42.2842782|*|-83.7345314|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_mi.html|*||*|,MD342343547|*|40.7709485|*|-111.8397483|*|30 N 1900 E|*|Salt Lake City|*|84132|*|UT|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ut.html|*||*|,UT342343022|*|34.073582|*|-118.380947|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ca1.html|*||*|,CA342343585|*|43.076345|*|-89.4313395|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_wi.html|*||*|,WI342343060|*|42.3361712|*|-71.1009382|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ma3.html|*||*|,MA342343624|*|37.5429664|*|-77.43505|*|612 E Marshall St|*|Richmond|*|23219|*|VA|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_va.html|*||*|,VA342343081|*|41.50464|*|-81.621627|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_oh1.html|*||*|,OH342342956|*|29.7099106|*|-95.4014139|*|1709 Dryden Rd|*|Houston|*|77030|*|TX|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_tx.html|*||*|,TX342343293|*|41.5059114|*|-81.6071514|*|11100 Euclid Ave|*|Cleveland|*|44106|*|OH|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_oh2.html|*||*|,OH342343340|*|39.1396644|*|-84.5042008|*|231 Albert Sabin Way|*|Cincinnati|*|45229|*|OH|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_oh3.html|*||*|,OH342343527|*|40.4419009|*|-79.9604392|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_pa2.html|*||*|,PA342343421|*|39.2904539|*|-76.623772|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_md.html|*||*|,MD342343564|*|44.384136|*|-73.199615|*|267 Maeck Farm Rd|*|Shelburne|*|05482|*|VT|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_vt.html|*||*|,VT342343600|*|36.1430277|*|-86.8000138|*|1211 21st Ave S|*|Nashville|*|37212|*|TN|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_tn.html|*||*|,TN342342939|*|33.909086|*|-84.350774|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ga.html|*||*|,GA342343006|*|41.7892569|*|-87.6049376|*|5841 S Maryland Ave|*|Chicago|*|60637|*|IL|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_il.html|*||*|,IL342343211|*|30.263886|*|-81.4428306|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_fl1.html|*||*|,FL342343150|*|32.8328365|*|-83.6295729|*|610 3rd St|*|Macon|*|31201|*|GA|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ga2.html|*||*|,GA342343197|*|40.78977|*|-73.952515|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ny2.html|*||*|,NY342343403|*|38.031627|*|-84.509255|*|800 Rose St|*|Lexington|*|40508|*|KY|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ky.html|*||*|,KY342343506|*|39.9518965|*|-75.1939518|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_pa1.html|*||*|,PA342343483|*|35.9131996|*|-79.0558445|*||*|Chapel Hill|*||*|NC|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_nc.html|*||*|,NC342343314|*|37.784511|*|-122.440412|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ca2.html|*||*|,CA342343641|*|36.0906339|*|-80.2715805|*|Medical Center Blvd|*|Winston-Salem|*|27103|*|NC|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_nc2.html|*||*|,NC342343662|*|35.8442108|*|-78.7125935|*|Duraleigh Rd|*|Raleigh|*|27612|*|NC|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_nc3.html|*||*|,NC342343461|*|44.9669985|*|-93.2370211|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/cra_mn3.html|*||*|,MN815234309|*|41.3735616|*|-81.83208049999996|*|18660 Bagley Road|*|Middleburg Heights|*|44130|*|Ohio|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-34.html|*||*|,OH815225476|*|38.0360467|*|-78.45516700000002|*|325 Winding River Lane|*|Charlottesville|*|22911|*|Virginia|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-22.html|*||*|,VA815227698|*|30.5148405|*|-87.21974469999998|*|8333 North Davis Highway|*|Pensacola|*|32514|*|Florida|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-25.html|*||*|,FL814655415|*|39.1790459|*|-76.84548010000003|*|7120 Minstrel Way|*|Columbia|*|21045|*|Maryland|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-2.html|*||*|,MD815230657|*|29.8517136|*|-97.94548789999999|*|1305 Wonder World Drive|*|San Marcos|*|78666|*|Texas|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-29.html|*||*|,TX815231313|*|29.11452109999999|*|-81.0237998|*|1690 Dunlawton Avenue|*|Port Orange|*|32127|*|Florida|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-31.html|*||*|,FL814674109|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-9.html|*||*|,MI815229165|*|39.782291|*|-104.76998800000001|*|18620 Green Valley Ranch Boulevard|*|Denver|*|80249|*|Colorado|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-27.html|*||*|,CO814673026|*|39.38348939999999|*|-74.57429769999999|*|3205 Fire Road|*|Egg Harbor Township|*|08234|*|New Jersey|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-7.html|*||*|,NJ814684851|*|36.7417665|*|-76.24615610000001|*|112 Gainsborough Square|*|Chesapeake|*|23320|*|Virginia|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-21.html|*||*|,VA814661503|*|32.502281|*|-92.111987|*|608 Grammont Street|*|Monroe|*|71201|*|Louisiana|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-5.html|*||*|,LA814681139|*|28.2545894|*|-82.18665809999999|*|38135 Market Square|*|Zephyrhills|*|33542|*|Florida|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-16.html|*||*|,FL814679183|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-13.html|*||*|,FL814655138|*|29.7713386|*|-94.98257100000001|*|1690 West Baker Road|*|Baytown|*|77521|*|Texas|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-1.html|*||*|,TX814682855|*|39.529818|*|-104.8717704|*|10103 RidgeGate Parkway|*|Lone Tree|*|80124|*|Colorado|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-17.html|*||*|,CO814676128|*|25.8208329|*|-80.28562779999999|*|286 Westward Drive|*|Miami Springs|*|33166|*|Florida|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-11.html|*||*|,FL814677048|*|36.14242460000001|*|-86.80043969999997|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-12.html|*||*|,TN814670334|*|32.748867|*|-97.11962199999999|*|1009 Magnolia Street|*|Arlington|*|76012|*|Texas|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-6.html|*||*|,TX814680539|*|32.4438631|*|-93.71252170000002|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-15.html|*||*|,LA814659580|*|39.0069453|*|-94.57777329999999|*|6675 Holmes Road|*|Kansas City|*|64131|*|Missouri|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-4.html|*||*|,MO814657943|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-3.html|*||*|,TN815230066|*|30.4113199|*|-97.706098|*|12221 North Mopac Expressway|*|Austin|*|78758|*|Texas|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-28.html|*||*|,TX815233481|*|35.8210717|*|-78.70391269999999|*|3100 Blue Ridge Road|*|Raleigh|*|27612|*|North Carolina|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-33.html|*||*|,NC814675031|*|40.8853859|*|-111.86657730000002|*|425 Medical Drive|*|Bountiful|*|84010|*|Utah|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-10.html|*||*|,UT814683196|*|29.5181439|*|-98.56775240000002|*|8550 Datapoint Drive|*|San Antonio|*|78229|*|Texas|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-18.html|*||*|,TX815234779|*|43.0660277|*|-88.04858030000003|*|2645 North Mayfair Road|*|Wauwatosa|*|53226|*|Wisconsin|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-35.html|*||*|,WI815225964|*|39.6221207|*|-77.6838717|*|11110 Medical Campus Road|*|Hagerstown|*|21742|*|Maryland|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-23.html|*||*|,MD814684414|*|32.8326259|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-20.html|*||*|,GA814683492|*|32.9354834|*|-97.1084679|*|505 South Nolen Drive|*|Southlake|*|76092|*|Texas|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-19.html|*||*|,TX815227147|*|40.585985|*|-73.95326019999999|*|1517 Voorhies Avenue|*||*|11235|*|New York|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-24.html|*||*|,NY815232935|*|35.82359960000001|*|-78.70582379999996|*|3100 Duraleigh Road|*|Raleigh|*|27612|*|North Carolina|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-32.html|*||*|,NC815230982|*|35.0536652|*|-85.18214990000001|*|6035 Shallowford Road|*|Chattanooga|*|37421|*|Tennessee|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-30.html|*||*|,TN815228392|*|39.9717119|*|-105.09442509999997|*|380 Empire Road|*|Lafayette|*|80026|*|Colorado|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-26.html|*||*|,CO814664152|*|31.2231436|*|-85.43547719999998|*|480 Honeysuckle Road|*|Dothan|*|36305|*|Alabama|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-8.html|*||*|,AL814680059|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3898/combined-phase-2b3-14.html|*||*|,OH816053943|*|39.6221207|*|-77.6838717|*|11110 Medical Campus Road|*|Hagerstown|*|21742|*|Maryland|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-30.html|*||*|,MD816057741|*|35.82359960000001|*|-78.70582379999996|*|3100 Duraleigh Road|*|Raleigh|*|27612|*|North Carolina|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-40.html|*||*|,NC816051739|*|38.0360467|*|-78.45516700000002|*|325 Winding River Lane|*|Charlottesville|*|22911|*|Virginia|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-26.html|*||*|,VA816056044|*|29.8517136|*|-97.94548789999999|*|1305 Wonder World Drive|*|San Marcos|*|78666|*|Texas|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-35.html|*||*|,TX816058939|*|36.8529703|*|-76.193691|*|885 Kempsville Road|*|Norfolk|*|23502|*|Virginia|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-43.html|*||*|,VA815816108|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-3.html|*||*|,TN816058521|*|41.3735616|*|-81.83208049999996|*|18660 Bagley Road|*|Middleburg Heights|*|44130|*|Ohio|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-42.html|*||*|,OH816029455|*|36.14242460000001|*|-86.80043969999997|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-15.html|*||*|,TN816033217|*|32.4438631|*|-93.71252170000002|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-18.html|*||*|,LA816036201|*|28.2545894|*|-82.18665809999999|*|38135 Market Square|*|Zephyrhills|*|33542|*|Florida|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-19.html|*||*|,FL816032096|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-16.html|*||*|,FL816052488|*|39.7754962|*|-86.1766184|*|550 University Boulevard|*|Indianapolis|*|46202|*|Indiana|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-28.html|*||*|,IN815827434|*|25.8208329|*|-80.28562779999999|*|286 Westward Drive|*|Miami Springs|*|33166|*|Florida|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-13.html|*||*|,FL816050267|*|36.7417665|*|-76.24615610000001|*|112 Gainsborough Square|*|Chesapeake|*|23320|*|Virginia|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-24.html|*||*|,VA816039726|*|29.5181439|*|-98.56775240000002|*|8550 Datapoint Drive|*|San Antonio|*|78229|*|Texas|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-21.html|*||*|,TX815820060|*|32.502281|*|-92.111987|*|608 Grammont Street|*|Monroe|*|71201|*|Louisiana|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-6.html|*||*|,LA815821103|*|36.0800225|*|-86.71695139999997|*|330 Wallace Road|*|Nashville|*|37211|*|Tennessee|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-8.html|*||*|,TN816057349|*|29.96172619999999|*|-90.14609569999999|*|1514 Jefferson Highway|*|Jefferson|*|70121|*|Louisiana|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-39.html|*||*|,LA816053358|*|41.6598712|*|-91.54876039999999|*|200 Hawkins Drive|*|Iowa City|*|52242|*|Iowa|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-29.html|*||*|,IA815822917|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-11.html|*||*|,MI816056459|*|35.0536652|*|-85.18214990000001|*|6035 Shallowford Road|*|Chattanooga|*|37421|*|Tennessee|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-37.html|*||*|,TN815819446|*|36.1462952|*|-95.96682340000001|*|1145 South Utica Avenue|*|Tulsa|*|74104|*|Oklahoma|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-5.html|*||*|,OK816042241|*|32.9354834|*|-97.1084679|*|505 South Nolen Drive|*|Southlake|*|76092|*|Texas|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-22.html|*||*|,TX816056871|*|29.11452109999999|*|-81.0237998|*|1690 Dunlawton Avenue|*|Port Orange|*|32127|*|Florida|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-38.html|*||*|,FL816050798|*|29.7713386|*|-94.98257100000001|*|1690 West Baker Road|*|Baytown|*|77521|*|Texas|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-25.html|*||*|,TX815814511|*|39.1790459|*|-76.84548010000003|*|7120 Minstrel Way|*|Columbia|*|21045|*|Maryland|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-2.html|*||*|,MD816038187|*|39.529818|*|-104.8717704|*|10103 RidgeGate Parkway|*|Lone Tree|*|80124|*|Colorado|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-20.html|*||*|,CO816054720|*|25.7493941|*|-80.32194370000002|*|7815 Coral Way|*|Miami|*|33155|*|Florida|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-32.html|*||*|,FL816055623|*|30.5148405|*|-87.21974469999998|*|8333 North Davis Highway|*|Pensacola|*|32514|*|Florida|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-34.html|*||*|,FL816017130|*|41.7185303|*|-73.9295012|*|243 North Road|*|Poughkeepsie|*|12601|*|New York|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-14.html|*||*|,NY816032853|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-17.html|*||*|,OH816055202|*|29.6332323|*|-82.33886940000002|*|2001 Southwest 13th Street|*|Gainesville|*|32608|*|Florida|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-33.html|*||*|,FL816052064|*|33.001113|*|-96.68512269999997|*|3600 Shire Boulevard|*|Richardson|*|75082|*|Texas|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-27.html|*||*|,TX815822194|*|39.38348939999999|*|-74.57429769999999|*|3205 Fire Road|*|Egg Harbor Township|*|08234|*|New Jersey|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-10.html|*||*|,NJ816058247|*|35.8210717|*|-78.70391269999999|*|3100 Blue Ridge Road|*|Raleigh|*|27612|*|North Carolina|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-41.html|*||*|,NC815820658|*|31.2231436|*|-85.43547719999998|*|480 Honeysuckle Road|*|Dothan|*|36305|*|Alabama|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-7.html|*||*|,AL816042790|*|37.7797589|*|-122.3942839|*|610 3rd Street|*|San Francisco|*|94107|*|California|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-23.html|*||*|,MI,VA,AL,MN,UT,AZ,MO,NV,KY,LA,TX,TN,MD,OH,FL,OK,GA,IN,IA,WI,NJ,NY,CO,NC815824340|*|40.8853859|*|-111.86657730000002|*|425 Medical Drive|*|Bountiful|*|84010|*|Utah|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-12.html|*||*|,UT815821616|*|32.748867|*|-97.11962199999999|*|1009 Magnolia Street|*|Arlington|*|76012|*|Texas|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-9.html|*||*|,TX816054335|*|40.585985|*|-73.95326019999999|*|1517 Voorhies Avenue|*||*|11235|*|New York|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-31.html|*||*|,NY815818351|*|39.0069453|*|-94.57777329999999|*|6675 Holmes Road|*|Kansas City|*|64131|*|Missouri|*|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/gilead-2017/gs-us-419-3895/combined-phase-3-4.html|*||*|,MO675081168|*||*||*||*||*||*||*|Coping with Crohn’s and Colitis – Randomized Controlled Trial of a self-help workbook versus a psychoeducational workbook|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/university-of-pennsylvania/coping-with-crohns-and.html|*||*|,MI,MA,MS,MN,MT,MO,NV,NE,KS,KY,LA,MD,ME,ND,OH,OK,OR,PA,RI,SC,NH,NJ,NM,NY,NC,AK,AL,AZ,HI,ID,FL,GA,IN,IA,IL,CA,AR,DE,DC,CO,CT,AB,WA,VA,VT,UT,TX,TN,SD,WY,WI,WV677674010|*||*||*||*||*||*||*|Coping with Crohn’s and Colitis – Randomized Controlled Trial of a self-help workbook versus a psychoeducational workbook|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/current-research-studies/coping-with-crohns-and.html|*||*|,MI,MA,MS,MN,MT,MO,NV,NE,KS,KY,LA,MD,ME,ND,OH,OK,OR,PA,RI,SC,NH,NJ,NM,NY,NC,AZ,HI,ID,FL,GA,IN,IA,IL,CA,AR,DE,DC,CO,CT,WA,VA,VT,UT,TX,TN,SD,WY,WI,WV809066149|*|29.7098662|*|-95.3997134|*|6565 Fannin Street|*|Houston|*|77030|*|Texas|*|Copy of A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-66.html|*||*|,TX809075935|*|39.7685402|*|-105.08418599999999|*|7760 West 38th Avenue|*|Wheat Ridge|*|80033|*|Colorado|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-5.html|*||*|,CO809073196|*|39.0543146|*|-95.6922644|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-2.html|*||*|,KS809276151|*|32.3306493|*|-90.1742279|*|2500 North State Street|*|Jackson|*|39216|*|Mississippi|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-43.html|*||*|,MS809079562|*|35.9017871|*|-79.05351969999998|*|130 Mason Farm Road|*|Chapel Hill|*|27514|*|North Carolina|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-12.html|*||*|,NC809089056|*|41.7185303|*|-73.9295012|*|243 North Road|*|Poughkeepsie|*|12601|*|New York|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-28.html|*||*|,NY809081930|*|30.4160014|*|-91.08602300000001|*|9103 Jefferson Highway|*|Baton Rouge|*|70809|*|Louisiana|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-17.html|*||*|,LA809082323|*|37.4978455|*|-77.46685400000001|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|Virginia|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-18.html|*||*|,VA809078238|*|40.7736341|*|-73.96084389999999|*|130 East 77th Street|*|New York|*|10075|*|New York|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-9.html|*||*|,NY809273095|*|39.1330793|*|-84.50014779999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-36.html|*||*|,OH809086596|*|32.7404863|*|-117.16246760000001|*|3330 Third Avenue|*|San Diego|*|92103|*|California|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-24.html|*||*|,CA809274857|*|39.9866462|*|-105.10253510000001|*|1000 West South Boulder Road|*|Lafayette|*|80026|*|Colorado|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-39.html|*||*|,CO809087579|*|41.1353483|*|-112.06521800000002|*|1477 North 2000 West|*|Clinton|*|84015|*|Utah|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-26.html|*||*|,UT809279069|*|33.9096528|*|-84.3502722|*|5671 Peachtree Dunwoody Road|*|Atlanta|*|30342|*|Georgia|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-47.html|*||*|,GA809279426|*|38.3131106|*|-85.82020820000002|*|2630 Grant Line Road|*|New Albany|*|47150|*|Indiana|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-48.html|*||*|,IN809086215|*|42.5892136|*|-83.1710018|*|4600 Investment Drive|*|Troy|*|48098|*|Michigan|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-23.html|*||*|,MI809087181|*|32.876425|*|-117.22745700000002|*|9444 Medical Center Drive|*|San Diego|*|92037|*|California|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-25.html|*||*|,CA809077695|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-8.html|*||*|,TN809269659|*|28.5979386|*|-81.35830279999999|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|Florida|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-30.html|*||*|,FL809076520|*|39.5678996|*|-105.00106690000001|*|1001 Southpark Drive|*|Littleton|*|80120|*|Colorado|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-6.html|*||*|,CO809081481|*|40.7848037|*|-73.70848699999999|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-16.html|*||*|,NY809274198|*|41.7883128|*|-87.6045656|*|5841 South Maryland Avenue|*|Chicago|*|60637|*|Illinois|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-38.html|*||*|,IL809074551|*|42.2821207|*|-83.72735190000003|*|1500 East Medical Center Drive|*|Ann Arbor|*|48109|*|Michigan|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-3.html|*||*|,MI809271432|*|36.8529703|*|-76.193691|*|885 Kempsville Road|*|Norfolk|*|23502|*|Virginia|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-33.html|*||*|,VA809273708|*|38.8150189|*|-94.52112460000001|*|108 Congress|*|Belton|*|64012|*|Missouri|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-37.html|*||*|,MO809275869|*|37.7854864|*|-122.44022230000002|*|1701 Divisadero Street|*|San Francisco|*|94115|*|California|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-42.html|*||*|,CA809081122|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-15.html|*||*|,OH809085038|*|41.7114671|*|-87.77649180000003|*|9921 Southwest Highway|*|Oak Lawn|*|60453|*|Illinois|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-21.html|*||*|,IL809089688|*|34.0701958|*|-84.17311699999999|*|4395 Johns Creek Parkway|*|Suwanee|*|30024|*|Georgia|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-29.html|*||*|,GA809088626|*|35.5877405|*|-82.55223339999998|*|191 Biltmore Avenue|*|Asheville|*|28801|*|North Carolina|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-27.html|*||*|,NC809080038|*|28.500026|*|-81.37553880000002|*|3885 Oakwater Circle|*|Orlando|*|32806|*|Florida|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-13.html|*||*|,FL809271945|*|47.6213393|*|-122.18686049999997|*|1135 116th Avenue Northeast|*|Bellevue|*|98004|*|Washington|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-34.html|*||*|,WA809277883|*|34.256966|*|-119.22101900000001|*|1835 Knoll Drive|*|Ventura|*|93003|*|California|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-44.html|*||*|,CA809079222|*|32.8326259|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-11.html|*||*|,GA809278216|*|25.5992228|*|-80.34836330000002|*|18320 Franjo Road|*|Miami|*|33157|*|Florida|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-45.html|*||*|,FL809083878|*|36.1430712|*|-86.800297|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-19.html|*||*|,TN809075398|*|28.637398|*|-81.36448229999996|*|260 Lookout Place|*|Maitland|*|32751|*|Florida|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-4.html|*||*|,FL809085606|*|33.50366169999999|*|-86.80058729999996|*|1825 University Boulevard|*|Birmingham|*|35233|*|Alabama|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-22.html|*||*|,AL809077110|*|39.1390622|*|-84.50374210000001|*|231 Albert Sabin Way|*|Cincinnati|*|45229|*|Ohio|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-7.html|*||*|,OH809270664|*|40.7655563|*|-73.95531830000004|*|1305 York Avenue|*|New York|*|10021|*|New York|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-31.html|*||*|,NY809078696|*|39.0069453|*|-94.57777329999999|*|6675 Holmes Road|*|Kansas City|*|64131|*|Missouri|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-10.html|*||*|,MO809084519|*|32.7071591|*|-117.08608850000002|*|292 Euclid Avenue|*|San Diego|*|92114|*|California|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-20.html|*||*|,CA809275153|*|25.9722304|*|-80.29907479999997|*|11460 Interchange Circle North|*|Miramar|*|33025|*|Florida|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-40.html|*||*|,FL809278607|*|28.568163|*|-81.36397190000002|*|1817 North Mills Avenue|*|Orlando|*|32803|*|Florida|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-46.html|*||*|,FL809080589|*|32.4438631|*|-93.71252170000002|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-14.html|*||*|,LA809275474|*|42.0885944|*|-70.9884338|*|189 Quincy Street|*|Brockton|*|02302|*|Massachusetts|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-41.html|*||*|,MA809270986|*|33.9701741|*|-84.54789740000001|*|711 Canton Road|*|Marietta|*|30060|*|Georgia|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-32.html|*||*|,GA809272579|*|32.3299367|*|-95.28949239999997|*|1720 South Beckham Avenue|*|Tyler|*|75701|*|Texas|*|Cottonwood (GA28951): An open-label extension and safety monitoring study of moderate to severe ulcerative colitis patients enrolled in etrolizumab Phase II/III studies.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/cottonwood/cottonwood-ga28951-an-35.html|*||*|,TX751903881|*|29.6988339|*|-95.39407840000001|*|7200 Cambridge Street|*|Houston|*|77030|*|Texas|*|Development Of a Patient-Centered IBD Colorectal Communication Tool|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*||*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/baylor/colorectal-communication.html|*||*|,TX755437555|*|42.3516847|*|-71.07265669999998|*|419 Boylston Street|*|Boston|*|02116|*|Massachusetts|*|Ethical Issues in Prescription Drug Access under the Restricted Distribution Program for Tysabri|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/harvard-medical-brigham--womens/ethical-issues-in.html|*|5th Floor, Suite 500|*|,MA669002864|*||*||*||*||*||*||*|Genetics of Inflammatory Bowel Disease (IBD)|*|,crohns-disease,ulcerative-colitis|*|,adult-18,pediatric-under-18|*|,female,male|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mount-sinai/genetics-of-inflammatory.html|*||*|,NY806822577|*|39.1390622|*|-84.50374210000001|*|231 Albert Sabin Way|*|Cincinnati|*|45229|*|Ohio|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-13.html|*||*|,OH806818293|*|39.739686|*|-105.07482829999998|*|7000 West Colfax Avenue|*|Lakewood|*|80214|*|Colorado|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-4.html|*||*|,CO806817636|*|39.4474704|*|-75.04024609999999|*|602 West Sherman Avenue|*|Vineland|*|08360|*|New Jersey|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-3.html|*||*|,NJ806818769|*|41.1542481|*|-111.94184439999998|*|5896 South Ridgeline Drive|*|South Ogden|*|84405|*|Utah|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-5.html|*||*|,UT806821009|*|32.8326258|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-10.html|*||*|,GA806820160|*|41.78828650000001|*|-87.60467260000001|*|5841 South Maryland Avenue|*|Chicago|*|60637|*|Illinois|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-8.html|*||*|,IL806820548|*|27.8715632|*|-82.7403678|*|7300 Bryan Dairy Road|*|Largo|*|33777|*|Florida|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-9.html|*||*|,FL806819340|*|30.4160014|*|-91.08602300000001|*|9103 Jefferson Highway|*|Baton Rouge|*|70809|*|Louisiana|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-6.html|*||*|,LA806822116|*|42.5891846|*|-83.16958190000003|*|4550 Investment Drive|*|Troy|*|48098|*|Michigan|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-12.html|*||*|,MI806821509|*|32.707159|*|-117.08608850000002|*|292 Euclid Avenue|*|San Diego|*|92114|*|California|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-11.html|*||*|,CA806819783|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-7.html|*||*|,FL806647157|*|28.637353|*|-81.36459100000002|*|260 Lookout Place|*|Maitland|*|32751|*|Florida|*|Hibiscus 1 (GA28948): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-i/hibiscus-1-ga28948-phase-2.html|*||*|,FL806832018|*|32.9764353|*|-80.06425430000002|*|2695 Elms Plantation Boulevard|*|Charleston|*|29406|*|South Carolina|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-13.html|*||*|,SC806825170|*|39.0069453|*|-94.57777329999999|*|6675 Holmes Road|*|Kansas City|*|64131|*|Missouri|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-4.html|*||*|,MO806827498|*|40.7848037|*|-73.70848699999999|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-7.html|*||*|,NY806831640|*|39.38348939999999|*|-74.57429769999999|*|3205 Fire Road|*|Egg Harbor Township|*|08234|*|New Jersey|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-12.html|*||*|,NJ806828510|*|41.7185303|*|-73.9295012|*|243 North Road|*|Poughkeepsie|*|12601|*|New York|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-8.html|*||*|,NY806830454|*|33.7913095|*|-84.28368130000001|*|2665 North Decatur Road|*|Decatur|*|30033|*|Georgia|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-10.html|*||*|,GA806823170|*|39.0543147|*|-95.69226429999998|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-2.html|*||*|,KS806829811|*|40.7814905|*|-73.71585040000002|*|600 Northern Boulevard|*|Great Neck|*|11021|*|New York|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-9.html|*||*|,NY806831167|*|36.0800225|*|-86.71695139999997|*|330 Wallace Road|*|Nashville|*|37211|*|Tennessee|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-11.html|*||*|,TN806826536|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-6.html|*||*|,OH806825865|*|28.500026|*|-81.37553869999999|*|3885 Oakwater Circle|*|Orlando|*|32806|*|Florida|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-5.html|*||*|,FL806823904|*|39.5678996|*|-105.00106690000001|*|1001 Southpark Drive|*|Littleton|*|80120|*|Colorado|*|Hibiscus 2 (GA28949): Phase III, randomized, double-blind, double-dummy comparison between etrolizumab with adalimumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hibiscus-ii/hibiscus-2-ga28949-phase-3.html|*||*|,CO811702100|*|40.7660738|*|-73.95501680000001|*|1315 York Avenue|*|New York|*|10021|*|New York|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-36.html|*||*|,NY811693277|*|37.4978455|*|-77.46685400000001|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|Virginia|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-25.html|*||*|,VA811706287|*|37.7854864|*|-122.44022230000002|*|1701 Divisadero Street|*|San Francisco|*|94115|*|California|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-45.html|*||*|,CA811534284|*|39.5678996|*|-105.00106690000001|*|1001 Southpark Drive|*|Littleton|*|80120|*|Colorado|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-8.html|*||*|,CO811708635|*|25.9261728|*|-80.16280740000002|*|1865 Northeast 163rd Street|*|North Miami Beach|*|33162|*|Florida|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-51.html|*||*|,FL811691794|*|36.14242460000001|*|-86.80043969999997|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-23.html|*||*|,TN811703380|*|47.6213393|*|-122.18686049999997|*|1135 116th Avenue Northeast|*|Bellevue|*|98004|*|Washington|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-39.html|*||*|,WA811691026|*|41.7900229|*|-87.60565009999999|*|5758 South Maryland Avenue|*|Chicago|*|60637|*|Illinois|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-22.html|*||*|,IL811532436|*|38.2467724|*|-85.74701099999999|*|627 South Preston Street|*|Louisville|*|40202|*|Kentucky|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-3.html|*||*|,KY811698212|*|41.7114671|*|-87.77649180000003|*|9921 Southwest Highway|*|Oak Lawn|*|60453|*|Illinois|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-30.html|*||*|,IL811700294|*|35.5877405|*|-82.55223339999998|*|191 Biltmore Avenue|*|Asheville|*|28801|*|North Carolina|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-32.html|*||*|,NC811685836|*|30.4160014|*|-91.08602300000001|*|9103 Jefferson Highway|*|Baton Rouge|*|70809|*|Louisiana|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-18.html|*||*|,LA811532865|*|42.2821207|*|-83.72735190000003|*|1500 East Medical Center Drive|*|Ann Arbor|*|48109|*|Michigan|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-4.html|*||*|,MI811533163|*|28.637398|*|-81.36448229999996|*|260 Lookout Place|*|Maitland|*|32751|*|Florida|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-5.html|*||*|,FL811688012|*|39.4745794|*|-119.79771390000002|*|645 Sierra Rose Drive|*|Reno|*|89509|*|Nevada|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-20.html|*||*|,NV811692363|*|37.7674169|*|-122.39032220000001|*|550 16th Street|*|San Francisco|*|94158|*|California|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-24.html|*||*|,CA811701590|*|42.3618175|*|-71.06579339999996|*|165 Cambridge Street|*|Boston|*|02114|*|Massachusetts|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-35.html|*||*|,MA811533992|*|39.739686|*|-105.07482829999998|*|7000 West Colfax Avenue|*|Lakewood|*|80214|*|Colorado|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-7.html|*||*|,CO811703937|*|36.8529703|*|-76.193691|*|885 Kempsville Road|*|Norfolk|*|23502|*|Virginia|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-40.html|*||*|,VA811534642|*|40.7739485|*|-73.96057639999998|*|130 East 77th Street|*|New York|*|10075|*|New York|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-9.html|*||*|,NY811695144|*|32.876425|*|-117.22745700000002|*|9444 Medical Center Drive|*|San Diego|*|92037|*|California|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-27.html|*||*|,CA811696430|*|33.5079488|*|-86.8002573|*|2000 6th Avenue South|*|Birmingham|*|35233|*|Alabama|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-28.html|*||*|,AL811689106|*|32.4438631|*|-93.71252170000002|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-21.html|*||*|,LA811683315|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-15.html|*||*|,FL811704434|*|33.9198757|*|-84.36207430000002|*|750 Hammond Drive|*|Atlanta|*|30328|*|Georgia|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-41.html|*||*|,GA811687071|*|40.7848037|*|-73.70848699999999|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-19.html|*||*|,NY811680696|*|39.0069453|*|-94.57777329999999|*|6675 Holmes Road|*|Kansas City|*|64131|*|Missouri|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-13.html|*||*|,MO811701165|*|28.5979386|*|-81.35830279999999|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|Florida|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-34.html|*||*|,FL811702982|*|33.9701741|*|-84.54789740000001|*|711 Canton Road|*|Marietta|*|30060|*|Georgia|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-38.html|*||*|,GA811679597|*|41.1542481|*|-111.94184439999998|*|5896 South Ridgeline Drive|*|South Ogden|*|84405|*|Utah|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-12.html|*||*|,UT811678631|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-11.html|*||*|,TN811699735|*|41.1353483|*|-112.06521800000002|*|1477 North 2000 West|*|Clinton|*|84015|*|Utah|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-31.html|*||*|,UT811705888|*|41.8945824|*|-87.62317310000003|*|676 North Saint Clair Street|*|Chicago|*|60611|*|Illinois|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-44.html|*||*|,IL811706617|*|44.0226729|*|-92.4667508|*|200 1st Street Southwest|*|Rochester|*|55902|*|Minnesota|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-46.html|*||*|,MN811707088|*|25.9722304|*|-80.29907479999997|*|11460 Interchange Circle North|*|Miramar|*|33025|*|Florida|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-47.html|*||*|,FL811533621|*|35.9017871|*|-79.05351969999998|*|130 Mason Farm Road|*|Chapel Hill|*|27514|*|North Carolina|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-6.html|*||*|,NC811684054|*|32.7071591|*|-117.08608850000002|*|292 Euclid Avenue|*|San Diego|*|92114|*|California|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-16.html|*||*|,CA811682090|*|32.8326259|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-14.html|*||*|,GA811700730|*|34.0701958|*|-84.17311699999999|*|4395 Johns Creek Parkway|*|Suwanee|*|30024|*|Georgia|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-33.html|*||*|,GA811697199|*|32.7404863|*|-117.16246760000001|*|3330 Third Avenue|*|San Diego|*|92103|*|California|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-29.html|*||*|,WA,MI,VA,MA,AL,MN,UT,MO,NV,KS,KY,LA,TX,TN,OH,FL,GA,IL,SC,CA,NY,CO,NC811707431|*|40.7705157|*|-111.83572170000002|*|30 North 1900 East|*|Salt Lake City|*|84132|*|Utah|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-48.html|*||*|,UT811677198|*|39.1390622|*|-84.50374210000001|*|231 Albert Sabin Way|*|Cincinnati|*|45229|*|Ohio|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-10.html|*||*|,OH811707868|*|28.500026|*|-81.37553880000002|*|3885 Oakwater Circle|*|Orlando|*|32806|*|Florida|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-49.html|*||*|,FL811685300|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-17.html|*||*|,OH811702574|*|32.3299367|*|-95.28949239999997|*|1720 South Beckham Avenue|*|Tyler|*|75701|*|Texas|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-37.html|*||*|,TX811694039|*|42.5891846|*|-83.16958190000003|*|4550 Investment Drive|*|Troy|*|48098|*|Michigan|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-26.html|*||*|,MI811704948|*|39.1330793|*|-84.50014779999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-42.html|*||*|,OH811531881|*|39.0543146|*|-95.6922644|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-2.html|*||*|,KS811708252|*|32.7836505|*|-79.95183329999998|*|25 Courtenay Drive|*|Charleston|*|29401|*|South Carolina|*|Hickory (GA28950): Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have a less than adequate response to TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/hickory/hickory-ga28950-phase-iii-50.html|*||*|,SC803797914|*|32.4438631|*|-93.71252179999999|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-3.html|*||*|,LA803866993|*|25.7817507|*|-80.31304190000003|*|1150 Northwest 72nd Avenue|*|Miami|*|33126|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-49.html|*|Suite 700|*|,FL803842832|*|39.1330793|*|-84.50014779999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-29.html|*|Suite 730|*|,OH803807564|*|34.256966|*|-119.22101900000001|*|1835 Knoll Drive|*|Ventura|*|93003|*|California|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-9.html|*||*|,CA803843757|*|27.8715303|*|-82.75301939999997|*|8250 Bryan Dairy Road|*|Largo|*|33777|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-30.html|*||*|,FL803826435|*|37.4978455|*|-77.46685400000001|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|Virginia|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-18.html|*|McGuire DVAMC, GI 111N|*|,VA803840241|*|39.9717119|*|-105.09442509999997|*|380 Empire Road|*|Lafayette|*|80026|*|Colorado|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-27.html|*||*|,CO803818353|*|35.9017871|*|-79.05351969999998|*|130 Mason Farm Road|*|Chapel Hill|*|27514|*|North Carolina|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-13.html|*|4162 Bioinformatics|*|,NC803830931|*|36.1430712|*|-86.800297|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-21.html|*|Medical Arts Bldg, Suite 103|*|,TN803827968|*|43.0760624|*|-89.43396050000001|*|1685 Highland Avenue|*|Madison|*|53705|*|Wisconsin|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-19.html|*|Room 4124 MRCB|*|,WI803793130|*|40.1169199|*|-88.2148252|*|611 West Park Street|*|Urbana|*|61801|*|Illinois|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-1-1.html|*||*|,IL803802919|*|30.2507979|*|-81.5858493|*|4800 Belfort Road|*|Jacksonville|*|32256|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-6.html|*||*|,FL803824586|*|44.02262959999999|*|-92.46671219999996|*|200 1st Street Southwest|*|Rochester|*|55902|*|Minnesota|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-17.html|*||*|,MN803847326|*|29.114521|*|-81.0237998|*|1690 Dunlawton Avenue|*|Port Orange|*|32127|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-33.html|*|Suite 110|*|,FL803860423|*|25.7493941|*|-80.32194370000002|*|7815 Coral Way|*|Miami|*|33155|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-45.html|*||*|,FL803863863|*|34.2211582|*|-118.53720399999997|*|18531 Roscoe Boulevard|*|Los Angeles|*|91324|*|California|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-48.html|*|Suite 206|*|,CA803821442|*|47.6027056|*|-122.32213539999998|*|110 9th Avenue|*|Seattle|*|98104|*|Washington|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-15.html|*||*|,WA803850572|*|33.6098219|*|-117.71133800000001|*|24012 Calle De La Plata|*|Laguna Hills|*|92653|*|California|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-36.html|*||*|,CA803862429|*|25.8028262|*|-80.36572160000003|*|10454 Northwest 31st Terrace|*|Doral|*|33172|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-47.html|*||*|,FL803853958|*|42.498046|*|-83.43763799999999|*|39450 Twelve Mile Road|*|Novi|*|48377|*|Michigan|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-39.html|*||*|,MI803796140|*|32.8326258|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-2.html|*|Suite 204|*|,GA803832862|*|40.7716244|*|-111.83706469999998|*|50 North Medical Drive|*|Salt Lake City|*|84132|*|Utah|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-22.html|*|University of Utah|*|,UT803849713|*|28.5979386|*|-81.35830290000001|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-35.html|*||*|,FL803811206|*|42.2845877|*|-83.73424169999998|*|1150 West Medical Center Drive|*|Ann Arbor|*|48109|*|Michigan|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-11.html|*|6510 MSRB1|*|,MI803836681|*|32.3299367|*|-95.28949239999997|*|1720 South Beckham Avenue|*|Tyler|*|75701|*|Texas|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-25.html|*||*|,TX803809213|*|37.7674169|*|-122.39032220000001|*|550 16th Street|*|San Francisco|*|94158|*|California|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-10.html|*|5th Floor|*|,CA803835634|*|41.7114671|*|-87.77649180000003|*|9921 Southwest Highway|*|Oak Lawn|*|60453|*|Illinois|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-24.html|*||*|,IL803845914|*|41.8945731|*|-87.62159500000001|*|201 East Huron Street|*|Chicago|*|60611|*|Illinois|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-32.html|*|Suite 11-120|*|,IL803844784|*|28.2604685|*|-82.70694070000002|*|7114 Congress Street|*|New Port Richey|*|34653|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-31.html|*||*|,FL803854906|*|32.933042|*|-97.1085764|*|545 Nolen Drive|*|Southlake|*|76092|*|Texas|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-40.html|*||*|,TX803805650|*|38.2482465|*|-85.74555780000003|*|550 South Jackson Street|*|Louisville|*|40202|*|Kentucky|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-8.html|*|ACB 3rd Floor|*|,KY803822592|*|37.5009776|*|-122.25492459999998|*|1000 Laurel Street|*|San Carlos|*|94070|*|California|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-16.html|*||*|,CA803848633|*|35.2940427|*|-77.58770609999999|*|701 Doctors Drive|*|Kinston|*|28501|*|North Carolina|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-34.html|*||*|,NC803856947|*|42.8601928|*|-85.71584100000001|*|2093 Health Drive Southwest|*|Wyoming|*|49519|*|Michigan|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-42.html|*|Suite 201|*|,MI803868525|*|25.7471433|*|-80.35241500000001|*|9766 Southwest 24th Street|*|Miami|*|33165|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-50.html|*||*|,FL803829562|*|33.9701741|*|-84.54789740000001|*|711 Canton Road|*|Marietta|*|30060|*|Georgia|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-20.html|*|Suite 300|*|,GA803869350|*|25.7953672|*|-80.31909769999999|*|7500 Northwest 25th Street|*|Miami|*|33122|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-51.html|*||*|,FL803816842|*|28.637398|*|-81.36448229999996|*|260 Lookout Place|*|Maitland|*|32751|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-12.html|*||*|,FL803799701|*|25.9722304|*|-80.29907479999997|*|11460 Interchange Circle North|*|Miramar|*|33025|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-4.html|*||*|,FL803838058|*|30.4160014|*|-91.08602300000001|*|9103 Jefferson Highway|*|Baton Rouge|*|70809|*|Louisiana|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-26.html|*|2nd Floor Research|*|,LA803855802|*|43.4728257|*|-111.98917849999998|*|2770 Cortez Avenue|*|Idaho Falls|*|83404|*|Idaho|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-41.html|*||*|,ID803852766|*|32.3292625|*|-90.17425650000001|*|2500 North State Street|*|Jackson|*|39201|*|Mississippi|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-38.html|*|Stem Cell Lab|*|,MS803820339|*|39.739686|*|-105.07482829999998|*|7000 West Colfax Avenue|*|Lakewood|*|80214|*|Colorado|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-14.html|*||*|,CO803801294|*|39.0543147|*|-95.69226429999998|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-5.html|*||*|,KS803834265|*|42.5891846|*|-83.16958190000003|*|4550 Investment Drive|*|Troy|*|48098|*|Michigan|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-23.html|*||*|,MI803804288|*|38.8150189|*|-94.52112449999998|*|108 Congress|*|Belton|*|64012|*|Missouri|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-7.html|*||*|,MO803861503|*|33.7913095|*|-84.28368130000001|*|2665 North Decatur Road|*|Decatur|*|30033|*|Georgia|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-46.html|*|Suite 550|*|,GA803841161|*|41.5027329|*|-81.62015339999999|*|9500 Euclid Avenue|*|Cleveland|*|44195|*|Ohio|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-28.html|*||*|,OH803859594|*|28.568163|*|-81.36397190000002|*|1817 North Mills Avenue|*|Orlando|*|32803|*|Florida|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-44.html|*||*|,FL803858226|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-43.html|*|Suite 206|*|,MI803851714|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|Juniper (GA29145): An open-label extension and safety monitoring study of patients with moderately to severely active Crohn’s disease previously enrolled in the etrolizumab Phase III protocol GA29144.|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/juniper/juniper-ga29145-an-37.html|*||*|,TN806635268|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-31.html|*||*|,MI806640941|*|42.4952213|*|-83.3019046|*|28270 Franklin Road|*|Southfield|*|48034|*|Michigan|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-42.html|*||*|,MI806460701|*|32.4438631|*|-93.71252179999999|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-3.html|*||*|,LA806480586|*|25.9722304|*|-80.29907479999997|*|11460 Interchange Circle North|*|Miramar|*|33025|*|Florida|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-20.html|*||*|,FL806638096|*|29.114521|*|-81.0237998|*|1690 Dunlawton Avenue|*|Port Orange|*|32127|*|Florida|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-35.html|*||*|,FL806633540|*|32.3292625|*|-90.17425650000001|*|2500 North State Street|*|Jackson|*|39201|*|Mississippi|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-28.html|*||*|,MS806635739|*|25.5992229|*|-80.34836330000002|*|18320 Franjo Road|*|Miami|*|33157|*|Florida|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-32.html|*||*|,FL806478147|*|33.9701741|*|-84.54789740000001|*|711 Canton Road|*|Marietta|*|30060|*|Georgia|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-16.html|*||*|,GA806481444|*|42.0885944|*|-70.9884338|*|189 Quincy Street|*|Brockton|*|02302|*|Massachusetts|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-22.html|*||*|,MA806632960|*|32.933042|*|-97.1085764|*|545 Nolen Drive|*|Southlake|*|76092|*|Texas|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-27.html|*||*|,TX806476876|*|38.8150189|*|-94.52112449999998|*|108 Congress|*|Belton|*|64012|*|Missouri|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-14.html|*||*|,MO806630165|*|34.5908037|*|-86.9690579|*|1103 15th Avenue Southeast|*|Decatur|*|35601|*|Alabama|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-25.html|*||*|,AL803787893|*|38.0311849|*|-78.49882250000002|*|1215 Lee Street|*|Charlottesville|*|22908|*|Virginia|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-1.html|*||*|,VA806476253|*|39.1330793|*|-84.50014779999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-13.html|*||*|,OH806637610|*|25.9261728|*|-80.16280740000002|*|1865 Northeast 163rd Street|*|North Miami Beach|*|33162|*|Florida|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-34.html|*||*|,FL806474853|*|40.7660884|*|-73.95476969999999|*|1315 York Avenue|*|New York|*|10021|*|New York|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-10.html|*||*|,NY806632103|*|44.02262959999999|*|-92.46671219999996|*|200 1st Street Southwest|*|Rochester|*|55902|*|Minnesota|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-26.html|*||*|,MN806477470|*|40.7713016|*|-111.8393845|*|30 North 1900 East|*|Salt Lake City|*|84132|*|Utah|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-15.html|*||*|,UT806640634|*|38.3399339|*|-85.82812230000002|*|4023 Reas Lane|*|New Albany|*|47150|*|Indiana|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-41.html|*||*|,IN806634083|*|29.7105286|*|-95.39624140000001|*|1 Baylor Plaza|*|Houston|*|77030|*|Texas|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-29.html|*||*|,TX806481902|*|40.216683|*|-75.5418765|*|420 West Linfield-Trappe Road|*|Limerick|*|19468|*|Pennsylvania|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-23.html|*||*|,PA806472933|*|32.7404863|*|-117.16246760000001|*|3330 Third Avenue|*|San Diego|*|92103|*|California|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-8.html|*||*|,CA806453333|*|37.7674169|*|-122.39032220000001|*|550 16th Street|*|San Francisco|*|94158|*|California|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-2.html|*|Mail Code 0136|*|,CA806474349|*|28.5979386|*|-81.35830290000001|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|Florida|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-9.html|*||*|,FL806638890|*|29.5565942|*|-98.34821110000001|*|12850 Toepperwein Road|*|Live Oak|*|78233|*|Texas|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-37.html|*||*|,TX806637199|*|29.71068409999999|*|-95.40089519999998|*|6560 Fannin Street|*|Houston|*|77030|*|Texas|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-33.html|*||*|,TX806638490|*|32.812091|*|-96.84015970000002|*|5323 Harry Hines Boulevard|*|Dallas|*|75390|*|Texas|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-36.html|*||*|,TX806482274|*|34.5908037|*|-86.9690579|*|1103 15th Avenue Southeast|*|Decatur|*|35601|*|Alabama|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-24.html|*||*|,AL806470548|*|35.5877405|*|-82.55223339999998|*|191 Biltmore Avenue|*|Asheville|*|28801|*|North Carolina|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-7.html|*||*|,NC806640187|*|28.568163|*|-81.36397190000002|*|1817 North Mills Avenue|*|Orlando|*|32803|*|Florida|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-40.html|*||*|,FL806641297|*|25.7470957|*|-80.3541399|*|9820 Southwest 24th Street|*|Miami|*|33165|*|Florida|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-43.html|*||*|,FL806481114|*|34.801089|*|-92.217716|*|5106 Mc Clanahan Drive|*|North Little Rock|*|72116|*|Arkansas|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-21.html|*||*|,AR806639768|*|47.610072|*|-122.32256860000001|*|1221 Madison Street|*|Seattle|*|98104|*|Washington|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-39.html|*||*|,WA806645025|*|39.3918459|*|-76.61388360000001|*|7575 Osler Drive|*|Towson|*|21204|*|Maryland|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-44.html|*||*|,MD806478668|*|35.9017871|*|-79.05351969999998|*|130 Mason Farm Road|*|Chapel Hill|*|27514|*|North Carolina|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-17.html|*||*|,NC806479499|*|41.8945824|*|-87.62317310000003|*|676 North Saint Clair Street|*|Chicago|*|60611|*|Illinois|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-19.html|*||*|,IL806468351|*|41.7114671|*|-87.77649180000003|*|9921 Southwest Highway|*|Oak Lawn|*|60453|*|Illinois|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-5.html|*||*|,IL806469757|*|41.1353482|*|-112.06521800000002|*|1477 North 2000 West|*|Clinton|*|84015|*|Utah|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-6.html|*||*|,UT806634669|*|41.6022188|*|-93.78909399999998|*|1378 Northwest 124th Street|*|Clive|*|50325|*|Iowa|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-30.html|*||*|,IA806479098|*|39.9866462|*|-105.10253510000001|*|1000 West South Boulder Road|*|Lafayette|*|80026|*|Colorado|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-18.html|*||*|,CO806475226|*|47.6213393|*|-122.18686049999997|*|1135 116th Avenue Northeast|*|Bellevue|*|98004|*|Washington|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-11.html|*||*|,WA806639405|*|32.8814196|*|-96.76068800000002|*|8230 Walnut Hill Lane|*|Dallas|*|75231|*|Texas|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-38.html|*||*|,TX806475822|*|32.3299367|*|-95.28949239999997|*|1720 South Beckham Avenue|*|Tyler|*|75701|*|Texas|*|Laurel (GA29102): A Phase III, randomized, double-blind comparison between etrolizumab and placebo to evaluate efficacy and safety of etrolizumab in patients with active ulcerative colitis who have not been treated with TNF inhibitors.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/laurel/laurel-ga29102-a-phase-12.html|*||*|,TX811382068|*|42.3360489|*|-71.10683949999998|*|75 Francis Street|*|Boston|*|02115|*|Massachusetts|*|Low-dose IL-2 for ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/brigham-1/low-dose-il-2-for-ulcerative.html|*||*|,MA677234625|*|42.3360489|*|-71.10683949999998|*|75 Francis Street|*|Boston|*|02115|*|Massachusetts|*|Low-dose IL-2 for ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/brigham/low-dose-il-2-for-ulcerative.html|*||*|,MA677237851|*|42.3374145|*|-71.1055541|*|300 Longwood Avenue|*|Boston|*|02115|*|Massachusetts|*|Low-dose IL-2 for ulcerative colitis.|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/boston-childrens-/low-dose-il-2-for-ulcerative-1.html|*|Enders 670|*|,MA342346416|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_63.html|*||*|,WI342346266|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_55.html|*||*|342346037|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_42.html|*||*|,MA342346473|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_66.html|*||*|,MO342346353|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_60.html|*||*|,WI342346764|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_84.html|*||*|,NY342345436|*|41.2033216|*|-77.1945247|*||*||*||*|PA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_9.html|*||*|,PA342345990|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_39.html|*||*|,NY342346500|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_68.html|*||*|,NY342345593|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_18.html|*||*|,NC342346159|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_49.html|*||*|,MA342346486|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_67.html|*||*|,NY342345727|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_26.html|*||*|,NC342346397|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_62.html|*||*|,WI342346284|*|39.0457549|*|-76.6412712|*||*||*||*|MD|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_56.html|*||*|,MD342346378|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_61.html|*||*|,WI342346115|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_47.html|*||*|,NY342346175|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_50.html|*||*|342346070|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_44.html|*||*|,MA342346087|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_45.html|*||*|,NY342345474|*|40.6331249|*|-89.3985283|*||*||*||*|IL|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_11.html|*||*|,IL342345908|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_34.html|*||*|,MO342346101|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_46.html|*||*|,MA342345926|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_35.html|*||*|,MO342345833|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_31.html|*||*|,NC342345370|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_5.html|*||*|,CA342346603|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_74.html|*||*|,NY342346440|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_64.html|*||*|,WI342345976|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_38.html|*||*|,MA342346585|*|34.5199402|*|-105.8700901|*||*||*||*|NM|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_73.html|*||*|,NM342346569|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_72.html|*||*|,NY342346023|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_41.html|*||*|,MO342346823|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_87.html|*||*|,NY342345610|*|40.6331249|*|-89.3985283|*||*||*||*|IL|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_19.html|*||*|,IL342345457|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_10.html|*||*|,NC342345304|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_1.html|*||*|,CA342346790|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_85.html|*||*|,NY342345819|*|39.5500507|*|-105.7820674|*||*||*||*|CO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_30.html|*||*|,CO342345401|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_7.html|*||*|,NY342345712|*|32.1574351|*|-82.907123|*||*||*||*|GA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_25.html|*||*|,GA342346208|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_52.html|*||*|342345521|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_14.html|*||*|,NY342345626|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_20.html|*||*|,NC342345678|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_23.html|*||*|,NC342345770|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_28.html|*||*|,CA342346190|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_51.html|*||*|,MA342346516|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_69.html|*||*|,NY342346333|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_59.html|*||*|,NY342345322|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_2.html|*||*|,CA342345387|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_6.html|*||*|,NC342345663|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_22.html|*||*|,NC342345747|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_27.html|*||*|,NY342345692|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_24.html|*||*|,MA342346550|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_71.html|*||*|,NY342346729|*|46.818188|*|8.227512|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_82.html|*||*|342345797|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_29.html|*||*|,MO342345854|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_32.html|*||*|,NY342345536|*|31.9685988|*|-99.9018131|*||*||*||*|TX|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_15.html|*||*|,TX342345939|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_36.html|*||*|,CA342346007|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_40.html|*||*|,MO342345421|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_8.html|*||*|,NC342346632|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_76.html|*||*|,NY342346313|*|39.0457549|*|-76.6412712|*||*||*||*|MD|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_58.html|*||*|,MD342346458|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_65.html|*||*|,WI342346251|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_54.html|*||*|342345505|*|40.4172871|*|-82.907123|*||*||*||*|OH|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_13.html|*||*|,OH342346746|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_83.html|*||*|,NC342346701|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_80.html|*||*|,NC342345956|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_37.html|*||*|,MO342346138|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_48.html|*||*|,MA342345645|*|40.4172871|*|-82.907123|*||*||*||*|OH|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_21.html|*||*|,OH342346057|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_43.html|*||*|,MA342346717|*|46.818188|*|8.227512|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_81.html|*||*|342346671|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_78.html|*||*|,NY342345553|*|39.5500507|*|-105.7820674|*||*||*||*|CO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_16.html|*||*|,CO342345885|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_33.html|*||*|,NY342346650|*|31.9685988|*|-99.9018131|*||*||*||*|TX|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_77.html|*||*|,TX342346618|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_75.html|*||*|,NY342346805|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_86.html|*||*|,NY342346227|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_53.html|*||*|342346685|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_79.html|*||*|,NY342346532|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_70.html|*||*|,NY342346297|*|39.0457549|*|-76.6412712|*||*||*||*|MD|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_57.html|*||*|,MD342345336|*|38.8951118|*|-77.0363658|*||*|Washington|*||*|DC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_3.html|*||*|,DC342345352|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_4.html|*||*|,CA342345575|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_17.html|*||*|,MO342345489|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/micro_12.html|*||*|,MO474777339|*|41.873523|*|-87.67004|*|1725 West Harrison Street|*|Chicago|*|60612|*|IL|*|Mind/Body Medicine and Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,other|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mind-body.html|*||*|,IL743956370|*|44.0215784|*|-92.46448350000003|*|200 1st Avenue Southwest|*|Rochester|*|55902|*|Minnesota|*|Phase 1 Study of Autologous Mesenchymal Stem Cells in the Treatment of Perianal Fistulizing Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/mayo-clinic/faubionstudy.html|*||*|,MN818188009|*|39.955033|*|-75.19164380000001|*|24 South 34th Street|*|Philadelphia|*|19104|*|Pennsylvania|*|Phase Ib Escalating Dose, Open-Label, Signal-Finding Study to Evaluate the Safety, Tolerability, and Short-Term Efficacy of the Anti-Light Monoclonal MDGN-002 in Adults with Moderate to Severe Active Crohn’s Disease (CD) who have Failed Prior Treatment with an Anti-TNFα Agent, with and without Loss of Function Mutations in Decoy Receptor 3 (DcR3) (Anti-LIGHT in Anti-TNFα-Resistant Crohn’s Disease [TRaCk LIGHT])|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/aevi-genomic-medicine/phase-ib-escalating-dose.html|*||*|,PA808873818|*|34.8013057|*|-92.2165746|*||*|North Little Rock|*|72116|*|Arkansas|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-15.html|*||*|,AR809062778|*|33.79282300000001|*|-84.3194545|*|1365 Clifton Road|*|Atlanta|*|30322|*|Georgia|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-60.html|*||*|,GA809059752|*|29.5181439|*|-98.56775249999998|*|8550 Datapoint Drive|*|San Antonio|*|78229|*|Texas|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-58.html|*||*|,TX809055328|*|29.11452109999999|*|-81.0237998|*|1690 Dunlawton Avenue|*|Port Orange|*|32127|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-50.html|*||*|,FL809069471|*|25.7817507|*|-80.31304190000003|*|1150 Northwest 72nd Avenue|*|Miami|*|33126|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-72.html|*||*|,FL808892525|*|35.113164|*|-89.807704|*|1310 Wolf Park Drive|*|Germantown|*|38138|*|Tennessee|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-47.html|*||*|,TN809066785|*|42.3475004|*|-71.5110919|*|488 Boston Post Road East|*|Marlborough|*|01752|*|Massachusetts|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-67.html|*||*|,MA809056874|*|33.610525|*|-117.71033999999997|*|24221 Calle De La Louisa|*|Laguna Hills|*|92653|*|California|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-52.html|*||*|,CA808878446|*|41.3767488|*|-72.90484049999998|*|2200 Whitney Avenue|*|Hamden|*|06518|*|Connecticut|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-23.html|*||*|,CT808885570|*|33.9701741|*|-84.54789740000001|*|711 Canton Road|*|Marietta|*|30060|*|Georgia|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-36.html|*||*|,GA809055747|*|41.8945824|*|-87.62317310000003|*|676 North Saint Clair Street|*|Chicago|*|60611|*|Illinois|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-51.html|*||*|,IL808890701|*|41.5027329|*|-81.62015339999999|*|9500 Euclid Avenue|*|Cleveland|*|44195|*|Ohio|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-44.html|*||*|,OH809063745|*|28.568163|*|-81.36397190000002|*|1817 North Mills Avenue|*|Orlando|*|32803|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-61.html|*||*|,FL808882423|*|42.5891846|*|-83.16958190000003|*|4550 Investment Drive|*|Troy|*|48098|*|Michigan|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-29.html|*||*|,MI809069757|*|42.4952213|*|-83.3019046|*|28270 Franklin Road|*|Southfield|*|48034|*|Michigan|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-73.html|*||*|,MI808876942|*|32.8326258|*|-83.6295824|*|610 3rd Street|*|Macon|*|31201|*|Georgia|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-20.html|*||*|,GA808878939|*|40.1169199|*|-88.2148252|*|611 West Park Street|*|Urbana|*|61801|*|Illinois|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-24.html|*||*|,IL808873501|*|35.5877405|*|-82.55223339999998|*|191 Biltmore Avenue|*|Asheville|*|28801|*|North Carolina|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-14.html|*||*|,NC808883271|*|41.7900229|*|-87.60565009999999|*|5758 South Maryland Avenue|*|Chicago|*|60637|*|Illinois|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-31.html|*||*|,IL808890014|*|28.5979386|*|-81.35830290000001|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-42.html|*||*|,FL809068965|*|34.2211582|*|-118.53720399999997|*|18531 Roscoe Boulevard|*|Los Angeles|*|91324|*|California|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-71.html|*||*|,CA808882072|*|36.1430712|*|-86.800297|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-28.html|*||*|,TN808888401|*|41.7114671|*|-87.77649180000003|*|9921 Southwest Highway|*|Oak Lawn|*|60453|*|Illinois|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-38.html|*||*|,IL809065336|*|25.9261728|*|-80.16280740000002|*|1865 Northeast 163rd Street|*|North Miami Beach|*|33162|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-64.html|*||*|,FL808879572|*|28.637398|*|-81.36448229999996|*|260 Lookout Place|*|Maitland|*|32751|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-25.html|*||*|,FL808870473|*|39.4474704|*|-75.04024609999999|*|602 West Sherman Avenue|*|Vineland|*|08360|*|New Jersey|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-9.html|*||*|,NJ808885062|*|32.7844721|*|-79.95086739999999|*|114 Doughty Street|*|Charleston|*|29425|*|South Carolina|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-35.html|*||*|,SC809065713|*|33.7913095|*|-84.28368130000001|*|2665 North Decatur Road|*|Decatur|*|30033|*|Georgia|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-65.html|*||*|,GA809064401|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-62.html|*||*|,MI809070116|*|25.7953672|*|-80.31909769999999|*|7500 Northwest 25th Street|*|Miami|*|33122|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-74.html|*||*|,FL809057772|*|32.933042|*|-97.1085764|*|545 Nolen Drive|*|Southlake|*|76092|*|Texas|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-54.html|*||*|,TX808884490|*|40.7716244|*|-111.83706469999998|*|50 North Medical Drive|*|Salt Lake City|*|84132|*|Utah|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-34.html|*||*|,UT808882836|*|26.1595438|*|-81.79097809999996|*|1064 Goodlette-Frank Road|*|Naples|*|34102|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-30.html|*||*|,FL808890341|*|27.8715303|*|-82.75301939999997|*|8250 Bryan Dairy Road|*|Largo|*|33777|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-43.html|*||*|,FL809058706|*|43.4728257|*|-111.98917849999998|*|2770 Cortez Avenue|*|Idaho Falls|*|83404|*|Idaho|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-56.html|*||*|,ID808877481|*|39.0543147|*|-95.69226429999998|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-21.html|*||*|,KS808888860|*|32.3299367|*|-95.28949239999997|*|1720 South Beckham Avenue|*|Tyler|*|75701|*|Texas|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-39.html|*||*|,TX808883602|*|40.7738805|*|-73.96077359999998|*|100 East 77th Street|*|New York|*|10075|*|New York|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-32.html|*||*|,NY809070754|*|25.7471433|*|-80.35241500000001|*|9766 Southwest 24th Street|*|Miami|*|33165|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-75.html|*||*|,FL808891171|*|39.1330793|*|-84.50014779999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-45.html|*||*|,OH809057454|*|42.498046|*|-83.43763799999999|*|39450 Twelve Mile Road|*|Novi|*|48377|*|Michigan|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-53.html|*||*|,MI808884108|*|25.5992415|*|-80.34815609999998|*|18320 Southwest 97th Avenue|*|Palmetto Bay|*|33157|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-33.html|*||*|,FL808864069|*|32.4438631|*|-93.71252179999999|*|1800 East 70th Street|*|Shreveport|*|71105|*|Louisiana|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-2.html|*||*|,LA808874807|*|37.4978455|*|-77.46685400000001|*|1201 Broad Rock Boulevard|*|Richmond|*|23249|*|Virginia|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-16.html|*||*|,VA809071645|*|47.610072|*|-122.32256860000001|*|1221 Madison Street|*|Seattle|*|98104|*|Washington|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-77.html|*||*|,WA808892088|*|40.7660884|*|-73.95476969999999|*|1315 York Avenue|*|New York|*|10021|*|New York|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-46.html|*||*|,NY808887889|*|43.0760624|*|-89.43396050000001|*|1685 Highland Avenue|*|Madison|*|53705|*|Wisconsin|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-37.html|*||*|,WI809067609|*|42.0885944|*|-70.9884338|*|189 Quincy Street|*|Brockton|*|02302|*|Massachusetts|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-68.html|*||*|,MA808865490|*|38.8150189|*|-94.52112449999998|*|108 Congress|*|Belton|*|64012|*|Missouri|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-3.html|*||*|,MO808889153|*|30.4160014|*|-91.08602300000001|*|9103 Jefferson Highway|*|Baton Rouge|*|70809|*|Louisiana|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-40.html|*||*|,LA808875170|*|32.876425|*|-117.22745700000002|*|9444 Medical Center Drive|*|San Diego|*|92037|*|California|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-17.html|*||*|,CA808875759|*|44.02262959999999|*|-92.46671219999996|*|200 1st Street Southwest|*|Rochester|*|55902|*|Minnesota|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-18.html|*||*|,MN808872879|*|37.5009776|*|-122.25492459999998|*|1000 Laurel Street|*|San Carlos|*|94070|*|California|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-13.html|*||*|,CA809054063|*|35.2940427|*|-77.58770609999999|*|701 Doctors Drive|*|Kinston|*|28501|*|North Carolina|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-48.html|*||*|,NC809068113|*|25.8028262|*|-80.36572160000003|*|10454 Northwest 31st Terrace|*|Doral|*|33172|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-69.html|*||*|,FL808871916|*|41.7185303|*|-73.9295012|*|243 North Road|*|Poughkeepsie|*|12601|*|New York|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-12.html|*||*|,NY808867219|*|34.256966|*|-119.22101900000001|*|1835 Knoll Drive|*|Ventura|*|93003|*|California|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-6.html|*||*|,CA808877890|*|25.9722304|*|-80.29907479999997|*|11460 Interchange Circle North|*|Miramar|*|33025|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-22.html|*||*|,FL809068547|*|32.8814196|*|-96.76068800000002|*|8230 Walnut Hill Lane|*|Dallas|*|75231|*|Texas|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-70.html|*||*|,TX808876466|*|29.6991505|*|-95.3945731|*|7200 Cambridge Street|*|Houston|*|77030|*|Texas|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-19.html|*||*|,TX808870985|*|47.6094749|*|-122.32790779999999|*|1100 9th Avenue|*|Seattle|*|98101|*|Washington|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-10.html|*||*|,WA808881301|*|30.2507979|*|-81.5858493|*|4800 Belfort Road|*|Jacksonville|*|32256|*|Florida|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-27.html|*||*|,FL808869797|*|42.2814471|*|-83.73015250000003|*|1150 East Medical Center Drive|*|Ann Arbor|*|48109|*|Michigan|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-8.html|*||*|,MI809058195|*|32.3292625|*|-90.17425650000001|*|2500 North State Street|*|Jackson|*|39201|*|Mississippi|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-55.html|*||*|,MS809064749|*|40.7848037|*|-73.70848699999999|*|1000 Northern Boulevard|*|Great Neck|*|11020|*|New York|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-63.html|*||*|,NY808866657|*|38.2482465|*|-85.74555780000003|*|550 South Jackson Street|*|Louisville|*|40202|*|Kentucky|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-5.html|*||*|,KY808867833|*|37.7674169|*|-122.39032220000001|*|550 16th Street|*|San Francisco|*|94158|*|California|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-7.html|*||*|,CA809060473|*|42.8601928|*|-85.71584100000001|*|2093 Health Drive Southwest|*|Wyoming|*|49519|*|Michigan|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-59.html|*||*|,MI808865939|*|41.1353482|*|-112.06521800000002|*|1477 North 2000 West|*|Clinton|*|84015|*|Utah|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-4.html|*||*|,UT808889717|*|39.9717119|*|-105.09442509999997|*|380 Empire Road|*|Lafayette|*|80026|*|Colorado|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-41.html|*||*|,CO808880088|*|35.9017871|*|-79.05351969999998|*|130 Mason Farm Road|*|Chapel Hill|*|27514|*|North Carolina|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-26.html|*||*|,NC808871540|*|39.739686|*|-105.07482829999998|*|7000 West Colfax Avenue|*|Lakewood|*|80214|*|Colorado|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-11.html|*||*|,CO809071124|*|33.537975|*|-80.82602199999997|*|1131 Cook Road|*|Orangeburg|*|29118|*|South Carolina|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-76.html|*||*|,SC809059427|*|41.68250760000001|*|-81.30038669999999|*|9485 Mentor Avenue|*|Mentor|*|44060|*|Ohio|*|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn's Disease (Bergamot; GA29144)|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/genentech/bergamot/a-phase-iii-randomized-57.html|*||*|,OH807303880|*|41.1990643|*|-73.20160829999998|*|2660 Main Street|*|Bridgeport|*|06606|*|Connecticut|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-17.html|*||*|,CT806846100|*|35.82359960000001|*|-78.70582379999996|*|3100 Duraleigh Road|*|Raleigh|*|27612|*|North Carolina|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-4.html|*||*|,NC807298441|*|39.022058|*|-84.56070499999998|*|425 Centre View Boulevard|*|Crestview Hills|*|41017|*|Kentucky|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-11.html|*||*|,KY807301111|*|42.0885944|*|-70.9884338|*|189 Quincy Street|*|Brockton|*|02302|*|Massachusetts|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-14.html|*||*|,MA806844939|*|32.7731847|*|-91.91437580000002|*|616 South Washington Street|*|Bastrop|*|71220|*|Louisiana|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-3.html|*||*|,LA807297983|*|38.9639621|*|-77.0904337|*|5550 Friendship Boulevard|*|Chevy Chase|*|20815|*|Maryland|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-10.html|*||*|,MD806848490|*|42.6763163|*|-82.80608649999999|*|30795 23 Mile Road|*|Chesterfield|*|48047|*|Michigan|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-7.html|*||*|,MI807302271|*|39.0543147|*|-95.69226429999998|*|720 Southwest Lane Street|*|Topeka|*|66606|*|Kansas|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-15.html|*||*|,KS807300560|*|31.2231436|*|-85.43547719999998|*|480 Honeysuckle Road|*|Dothan|*|36305|*|Alabama|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-13.html|*||*|,AL806849126|*|42.9899706|*|-87.95078639999997|*|2801 West Kinnickinnic River Parkway|*|Milwaukee|*|53215|*|Wisconsin|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-8.html|*||*|,WI807303319|*|32.6397734|*|-117.07797119999998|*|353 Church Avenue|*|Chula Vista|*|91910|*|California|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-16.html|*||*|,CA806847923|*|30.2507979|*|-81.5858493|*|4800 Belfort Road|*|Jacksonville|*|32256|*|Florida|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-6.html|*||*|,FL807299280|*|34.13673000000001|*|-117.37160080000001|*|2006 North Riverside Avenue|*|Rialto|*|92377|*|California|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-12.html|*||*|,CA806847597|*|35.5877405|*|-82.55223339999998|*|191 Biltmore Avenue|*|Asheville|*|28801|*|North Carolina|*|PIONEER-CD: A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects with Crohn’s Disease (CD) Receiving Anti-TNF Therapy|*|,crohns-disease|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/prometheus-2017/pioneer-cd/a-randomized-double-blind-5.html|*||*|,NC342344510|*|32.8089195|*|-96.8360682|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_124.html|*||*|,TX342344305|*|35.9131996|*|-79.0558445|*||*|Chapel Hill|*||*|NC|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_112.html|*||*|,NC342343869|*|40.2859239|*|-76.6502468|*||*|Hershey|*||*|PA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_136.html|*||*|,PA342344402|*|40.77225|*|-111.841536|*|50 N Medical Dr|*|Salt Lake City|*|84112|*|UT|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_118.html|*||*|,UT342344556|*|30.243503|*|-81.547479|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_126.html|*||*|,FL342343681|*|40.295635|*|-73.985181|*|300 2nd Ave|*|Long Branch|*|07740|*|NJ|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_130.html|*||*|,NJ342344095|*|39.954329|*|-75.191779|*|S 34th St|*|Philadelphia|*|19104|*|PA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_103.html|*||*|,PA342344597|*|45.3990082|*|-75.6530866|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_129.html|*||*|342344117|*|39.1031182|*|-84.5120196|*||*|Cincinnati|*||*|OH|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_104.html|*||*|,OH342344573|*|42.909397|*|-78.875503|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_127.html|*||*|,NY342344491|*|41.7884212|*|-87.6040232|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_123.html|*||*|,IL342344353|*|44.6388704|*|-63.5824473|*|5850 University Ave|*|Halifax|*||*|NS|*|PROKIIDS |*|,crohns-disease|*||*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_115.html|*||*|342344336|*|40.7881467|*|-74.4652262|*|100 Madison Ave|*|Morristown|*|07960|*|NJ|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_114.html|*||*|,NJ342343786|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_134.html|*||*|,NY342343988|*|38.6215188|*|-90.2383805|*|1465 S Grand Blvd|*|St Louis|*|63104|*|MO|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_140.html|*||*|,MO342343706|*|41.9253231|*|-87.6468578|*|2300 N Childrens Plaza|*|Chicago|*|60614|*|IL|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_131.html|*||*|,IL342344528|*|34.0641662|*|-118.442186|*|10833 Le Conte Ave|*|Los Angeles|*|90095|*|CA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_125.html|*||*|,CA342344321|*|43.6569435|*|-79.388988|*|555 University Ave|*|Toronto|*||*|ON|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_113.html|*||*|342344249|*|39.911802|*|-82.799209|*|3554 Creek Meadows Dr|*|Pickerington|*|43147|*|OH|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_109.html|*||*|,OH342343933|*|36.1589529|*|-115.1690117|*|2040 W Charleston Blvd|*|Las Vegas|*|89102|*|NV|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_138.html|*||*|,NV342344476|*|36.1388928|*|-86.802261|*|2200 Children's Way|*|Nashville|*|37212|*|TN|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_122.html|*||*|,TN342343763|*|40.7738568|*|-73.9607231|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_133.html|*||*|,NY342343964|*|41.5059114|*|-81.6071514|*|11100 Euclid Ave|*|Cleveland|*|44106|*|OH|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_139.html|*||*|,OH342344459|*|40.4659407|*|-79.9535709|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_121.html|*||*|,PA342343725|*|38.864347|*|-77.239632|*|8505 Arlington Blvd|*|Fairfax|*|22031|*|VA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_132.html|*||*|,VA342344368|*|39.777041|*|-86.179612|*|702 Barnhill Dr|*|Indianapolis|*|46201|*|IN|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_116.html|*||*|,IN342344003|*|43.1232753|*|-77.627698|*|601 Elmwood Ave|*|Rochester|*|14642|*|NY|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_141.html|*||*|,NY342344039|*|47.662622|*|-122.2822311|*|4800 Sand Point Way NE|*|Seattle|*|98105|*|WA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_143.html|*||*|,WA342344281|*|29.7079192|*|-95.4020717|*|6621 Fannin St|*|Houston|*|77030|*|TX|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_111.html|*||*|,TX342344384|*|33.9054263|*|-84.3569112|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_117.html|*||*|,GA342344206|*|40.7527106|*|-73.7074713|*|269-1 76th Ave|*|Queens|*|11040|*|NY|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_107.html|*||*|,NY342344444|*|39.297393|*|-76.59079|*|600 N Wolfe St|*|Baltimore|*|21205|*|MD|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_120.html|*||*|,MD342343898|*|39.2903848|*|-76.6121893|*||*|Baltimore|*||*|MD|*|PROKIIDS |*|,crohns-disease|*||*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_137.html|*||*|,MD342344167|*|43.043614|*|-88.020787|*|8701 W Watertown Plank Rd|*|Milwaukee|*|53226|*|WI|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_106.html|*||*|,WI342344142|*|41.7537933|*|-72.6826396|*|282 Washington St|*|Hartford|*|06106|*|CT|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_105.html|*||*|,CT342344262|*|42.3361712|*|-71.1009382|*|300 Longwood Ave|*|Boston|*|02115|*|MA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_110.html|*||*|,MA342344059|*|33.7980995|*|-84.3259367|*||*|Atlanta|*|30322|*|GA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_101.html|*||*|,GA342343838|*|40.7654867|*|-73.9543068|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_135.html|*||*|,NY342344024|*|39.0830928|*|-94.5801123|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_142.html|*||*|,MO342344418|*|41.8119019|*|-71.4089546|*|593 Eddy St|*|Providence|*|02903|*|RI|*|PROKIIDS |*|,crohns-disease|*||*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_119.html|*||*|,RI342344226|*|37.7749295|*|-122.4194155|*||*|San Francisco|*||*|CA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_108.html|*||*|,CA342344079|*|34.073582|*|-118.380947|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/pn_102.html|*||*|,CA798337683|*|36.180803|*|-86.60785799999996|*|5653 Frist Boulevard|*|Nashville|*|37076|*|Tennessee|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-17.html|*|Ste 730|*|,TN767649044|*|29.6991505|*|-95.3945731|*|7200 Cambridge Street|*|Houston|*|77030|*|Texas|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-13.html|*||*|,TX771621039|*|42.2845877|*|-83.73424169999998|*|1150 West Medical Center Drive|*|Ann Arbor|*|48109|*|Michigan|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-15.html|*||*|,MI798336950|*|36.142512|*|-86.80046440000001|*|1211 21st Avenue South|*|Nashville|*|37212|*|Tennessee|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-16.html|*|103C MAB|*|,TN751604347|*|41.3767488|*|-72.90484049999998|*|2200 Whitney Avenue|*|Hamden|*|06518|*|Connecticut|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-9.html|*|Ste 370|*|,CT749353031|*|39.1330978|*|-84.50013489999998|*|2925 Vernon Place|*|Cincinnati|*|45219|*|Ohio|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-6.html|*|Ste 200|*|,OH749349282|*|30.2507979|*|-81.5858493|*|4800 Belfort Road|*|Jacksonville|*|32256|*|Florida|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-3.html|*|Ste 301|*|,FL749337505|*|34.1368775|*|-117.37050490000001|*|2006 North Riverside Avenue|*|Rialto|*|92377|*|California|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-1.html|*|Ste A|*|,CA749351286|*|36.0774456|*|-80.2951251|*|1901 South Hawthorne Road|*|Winston-Salem|*|27103|*|North Carolina|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-5.html|*||*|,NC749350274|*|32.329267|*|-90.17422290000002|*|2500 North State Street|*|Jackson|*|39216|*|Mississippi|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-4.html|*|Room N424|*|,MS749339550|*|32.502281|*|-92.111987|*|608 Grammont Street|*|Monroe|*|71201|*|Louisiana|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-2.html|*||*|,LA764751529|*|34.0623919|*|-118.20199760000003|*|1510 San Pablo Street|*|Los Angeles|*|90033|*|California|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-11.html|*|Suite 322U|*|,CA769068881|*|37.9542317|*|-122.33796380000001|*|2089 Vale Road|*|San Pablo|*|94806|*|California|*|Protocol # I6T-MC-AMAC: A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody, in Patients with Moderate-to-Severe Ulcerative Colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/lilly/protocol--i6t-mc-amac/lily-amac-14.html|*|Ste 33|*|,CA356597010|*|40.7382965|*|-73.9777379|*|341 E 25th St|*|New York|*|10010|*|NY|*|Randomized double-blind placebo-controlled crossover study of Trichuris suis ova (TSO) in patients with established ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/MUCUS.html|*||*|,NY342344705|*|44.0221363|*|-92.4666658|*|200 1st St SW|*|Rochester|*|55902|*|MN|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_7.html|*||*|,NY453559707|*|41.7805099|*|-87.603826|*||*|Chicago|*|60637|*|IL|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/IL_01_Chicago.html|*||*|,IL342344780|*|38.0328237|*|-84.5067424|*||*|Lexington|*|40536|*|KY|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_12.html|*||*|,KY453571741|*|35.587751|*|-82.552185|*|191 Biltmore Avenue|*|Asheville|*|28801|*|NC|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/NC_03_Asheville.html|*||*|,NC453567631|*|40.7347832|*|-73.9898233|*|10 Union Square East #2g|*|New York|*|10003|*|NY|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/NY_02_New_York.html|*||*|,NY453551538|*|36.0044346|*|-78.9358171|*|200 Trent Drive|*|Durham|*|27710|*|NC|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/NC_02_Durham.html|*||*|,NC342344795|*|39.2914839|*|-76.6250795|*|620 W Lexington St|*|Baltimore|*|21201|*|MD|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_13.html|*||*|,MD452029542|*|35.2085398|*|-80.8221182|*|2015 Randolph Road|*|Charlotte|*|28207|*|NC|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/NC_01_Charlotte.html|*||*|,NC342344856|*|40.7704811|*|-111.8367368|*||*|Salt Lake City|*|84132|*|UT|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_18.html|*||*|,UT453622524|*|45.0243351|*|-93.4788847|*|15700 37th Avenue North #300|*|Plymouth|*|55446|*|MN|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/MN_01_Plymouth.html|*||*|,MN453562998|*|45.5116691|*|-122.7753981|*|9701 Southwest Barnes Road|*|Portland|*|97225|*|OR|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/OR_01_Portland.html|*||*|,OR342344845|*|40.4442094|*|-79.9565118|*|123 University Pl|*|Pittsburgh|*|15213|*|PA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_17.html|*||*|,PA342344632|*|29.709906|*|-95.40283|*|6620 Main St|*|Houston|*|77030|*|TX|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_2.html|*||*|,TX453566434|*|32.7835529|*|-79.9515562|*|25 Courtenay Drive|*|Charleston|*|29425|*|SC|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/SC_01_Charleston.html|*||*|,SC452047391|*||*||*||*||*||*||*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/merit-uc.html|*||*|,CA,CO,FL,GA,IL,IA,KY,MA,MN,NH,NY,NC,OH,PA,SC,TN,TX,UT342344693|*|42.3613606|*|-71.0653954|*|165 Cambridge Street|*|Boston|*|02114|*|MA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_6.html|*||*|,MA453624708|*|41.5072304|*|-81.6071674|*|11100 Euclid Avenue|*|Cleveland|*|44106|*|OH|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/OH_01_Cleveland.html|*||*|,OH342344681|*|46.7937341|*|-92.0952013|*|503 E 3rd St|*|Duluth|*|55805|*|MN|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_5.html|*||*|,MN453563906|*|38.2467887|*|-85.7473574|*|627 South Preston Street|*|Louisville|*|40202|*|KY|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/KY_01_Louisville.html|*||*|,KY342344819|*|35.901785|*|-79.0535174|*|130 Mason Farm Rd|*|Chapel Hill|*|27514|*|NC|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_15.html|*||*|,NC453557960|*|28.598041|*|-81.358368|*|701 West Morse Boulevard|*|Winter Park|*|32789|*|FL|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/FL_01_Winter_Park.html|*||*|,FL342344866|*|43.0766466|*|-89.4312429|*|600 Highland Ave|*|Madison|*|53792|*|WI|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_19.html|*||*|,WI342344834|*|39.952222|*|-75.192236|*|3451 Walnut St|*|Philadelphia|*|19104|*|PA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_16.html|*||*|,PA342344644|*|42.3362182|*|-71.0729293|*|85 E Concord St|*|Boston|*|02118|*|MA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_3.html|*||*|,MA342344734|*|40.7901076|*|-73.9539516|*|1 Gustave L. Levy Place|*|New York|*|10029|*|NY|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_9.html|*||*|,NY453553458|*|40.7851016|*|-73.7086053|*|1000 Northern Boulevard|*|Great Neck|*|11021|*|NY|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/NY_01_Great_Neck.html|*||*|,NY342344763|*|41.6569617|*|-91.5478736|*|200 Hawkins Dr|*|Iowa City|*|52242|*|IA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_11.html|*||*|,IA453619913|*|40.26466|*|-76.675773|*|500 University Drive|*|Hershey|*|17033|*|PA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/PA_01_Hershey.html|*||*|,PA453569934|*|39.7503186|*|-104.8367063|*||*|Aurora|*|80045|*|CO|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/CO_01_Aurora.html|*||*|,CO342344714|*|30.263886|*|-81.4428306|*|4500 San Pablo Rd S|*|Jacksonville|*|32224|*|FL|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_8.html|*||*|,FL342344749|*|37.786606|*|-122.449558|*|3333 California St|*|San Francisco|*|94118|*|CA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_10.html|*||*|,CA453555603|*|38.963947|*|-77.089841|*|5550 Friendship Boulevard|*|Chevy Chase|*|20815|*|MD|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/MD_01_Chevy_Chase.html|*||*|,MD342344616|*|33.909086|*|-84.350774|*|5671 Peachtree Dunwoody Rd NE|*|Atlanta|*|30342|*|GA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_1.html|*||*|,GA342344878|*|36.1399776|*|-86.8181055|*|3319 West End Ave|*|Nashville|*|37203|*|TN|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_20.html|*||*|,TN342344667|*|43.7097034|*|-72.2868263|*|11 Rope Ferry Rd|*|Hanover|*|03755|*|NH|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/muc_4.html|*||*|,NH655779786|*|40.7657186|*|-73.9541658|*|505 East 70th Street, New York, NY 10021, USA|*|New York|*|10021|*|NY|*|Sex Differences in Statural Growth Impairment in Pediatric Crohn's Disease (Growth Study)|*||*|,pediatric-under-18|*|,female,male|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/weill-cornell/sex-differences-in-statural.html|*||*|,NY789069343|*|42.3365993|*|-88.00713730000001|*|480 U.S. 45|*|Grayslake|*|60030|*|Illinois|*|Stool Sample Collection and Preservation Methods for Multiple Analytic Applications|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/abbvie-2017/stool-collection-study/stool-sample-collection-and-1.html|*||*|,IL519161962|*|39.2904708|*|-76.62403540000003|*|100 North Greene Street, Baltimore, MD 21201, USA|*|Baltimore|*|21201|*|MD|*|TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD) |*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,clinical-trials|*|http://www.crohnscolitisfoundation.org/research/participate-in-research/find-studies-and-clinical-trials/sponsor-profiles/tele-ibd/telemedicine-for-patients-1.html|*||*|,MD

IMPORTANT NOTE FOR CLINICAL TRIALS: The purpose of this registry is to provide information about ongoing clinical trials related to IBD. We do require that investigators who wish to be listed provide us with notification that the trial has been approved by their institutional review board (IRB), and each listing is reviewed by the Patient Education Committee of CCFA's National Scientific Advisory Committee. However, apart from studies that are funded by the Foundation, we do not endorse or ensure the scientific merit of trials listed in this registry. People who wish to participate in a study should discuss the opportunity with their personal physician.